
<html lang="en"     class="pb-page"  data-request-id="213bfa04-fc19-4f5a-ac10-7d1e4545e056"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2013.56.issue-3;website:website:acspubs;article:article:10.1021/jm301653f;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Systematic Exploration of Dual-Acting Modulators from a Combined Medicinal Chemistry and Biology Perspective" /></meta><meta name="dc.Creator" content="Aurelie  Bornot" /></meta><meta name="dc.Creator" content="Udo  Bauer" /></meta><meta name="dc.Creator" content="Alastair  Brown" /></meta><meta name="dc.Creator" content="Mike  Firth" /></meta><meta name="dc.Creator" content="Caroline  Hellawell" /></meta><meta name="dc.Creator" content="Ola  Engkvist" /></meta><meta name="dc.Description" content="The traditional drug discovery strategy of pursuing “one compound–one target” has had difficulties delivering novel therapies for complex diseases currently lacking adequate treatments. An alternat..." /></meta><meta name="Description" content="The traditional drug discovery strategy of pursuing “one compound–one target” has had difficulties delivering novel therapies for complex diseases currently lacking adequate treatments. An alternat..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 29, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301653f" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301653f" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301653f" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301653f" /></link>
        
    
    

<title>Systematic Exploration of Dual-Acting Modulators from a Combined Medicinal Chemistry and Biology Perspective | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301653f" /></meta><meta property="og:title" content="Systematic Exploration of Dual-Acting Modulators from a Combined Medicinal Chemistry and Biology Perspective" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0014.jpeg" /></meta><meta property="og:description" content="The traditional drug discovery strategy of pursuing “one compound–one target” has had difficulties delivering novel therapies for complex diseases currently lacking adequate treatments. An alternative and complementary approach is the design of multitargeted modulators simultaneously addressing multiple pathological mechanisms or overcoming pathway robustness. In this study, we propose a methodology to increase the probability of success for developing dual-acting modulators by systematically and rationally evaluating all dual-acting modulator opportunities within a specific disease area. This approach employs a combination of a five-step medicinal chemistry evaluation and a two-step biological analysis to help select the optimal target combination. It provides a novel methodology suitable for widespread application across disease areas. To exemplify the power of this approach, we focus on an analysis of the gastrointestinal (GI) disease area to identify opportunities supported by current literature data." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301653f"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301653f">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301653f&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301653f&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301653f&amp;href=/doi/10.1021/jm301653f" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1197-1210</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301648f" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301656h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Systematic Exploration of Dual-Acting Modulators from a Combined Medicinal Chemistry and Biology Perspective</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aurelie++Bornot">Aurelie Bornot</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Udo++Bauer">Udo Bauer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alastair++Brown">Alastair Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mike++Firth">Mike Firth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline++Hellawell">Caroline Hellawell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ola++Engkvist">Ola Engkvist</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Discovery Sciences, Computational Biology, AstraZeneca R&D, Alderley Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">iMED CV/GI, Medicinal Chemistry, AstraZeneca R&D, Pepparedsleden 1, Mölndal, SE-431 83, Sweden</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">iMED CV/GI, AstraZeneca R&D, Alderley Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Discovery Sciences, Computational Chemistry, AstraZeneca R&D, Pepparedsleden 1, Mölndal, SE-431 83, Sweden</span></div><div class="corresp-info"><strong>*</strong>corresponding author.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301653f&amp;href=/doi/10.1021%2Fjm301653f" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1197–1210</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 3, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 November 2012</li><li><span class="item_label"><b>Published</b> online</span>29 January 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 February 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301653f" title="DOI URL">https://doi.org/10.1021/jm301653f</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1197%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAurelie%2BBornot%252C%2BUdo%2BBauer%252C%2BAlastair%2BBrown%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D3%26contentID%3Djm301653f%26title%3DSystematic%2BExploration%2Bof%2BDual-Acting%2BModulators%2Bfrom%2Ba%2BCombined%2BMedicinal%2BChemistry%2Band%2BBiology%2BPerspective%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1210%26publicationDate%3DFebruary%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301653f"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1470</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301653f" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Systematic Exploration of Dual-Acting Modulators from a Combined Medicinal Chemistry and Biology Perspective&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Aurelie&quot;,&quot;last_name&quot;:&quot;Bornot&quot;},{&quot;first_name&quot;:&quot;Udo&quot;,&quot;last_name&quot;:&quot;Bauer&quot;},{&quot;first_name&quot;:&quot;Alastair&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Mike&quot;,&quot;last_name&quot;:&quot;Firth&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;Hellawell&quot;},{&quot;first_name&quot;:&quot;Ola&quot;,&quot;last_name&quot;:&quot;Engkvist&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;1197-1210&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301653f&quot;},&quot;abstract&quot;:&quot;The traditional drug discovery strategy of pursuing “one compound–one target” has had difficulties delivering novel therapies for complex diseases currently lacking adequate treatments. An alternative and complementary approach is the design of multitargeted modulators simultaneously addressing multiple pathological mechanisms or overcoming pathway robustness. In this study, we propose a methodology to increase the probability of success for developing dual-acting modulators by systematically and rationally evaluating all dual-acting modulator opportunities within a specific disease area. This approach employs a combination of a five-step medicinal chemistry evaluation and a two-step biological analysis to help select the optimal target combination. It provides a novel methodology suitable for widespread application across disease areas. To exemplify the power of this approach, we focus on an analysis of the gastrointestinal (GI) disease area to identify opportunities supported by current literature data.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301653f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301653f" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301653f&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301653f" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301653f&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301653f" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301653f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301653f&amp;href=/doi/10.1021/jm301653f" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301653f" /></input><a href="/doi/pdf/10.1021/jm301653f" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301653f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301653f%26sid%3Dliteratum%253Aachs%26pmid%3D23281966%26genre%3Darticle%26aulast%3DBornot%26date%3D2013%26atitle%3DSystematic%2BExploration%2Bof%2BDual-Acting%2BModulators%2Bfrom%2Ba%2BCombined%2BMedicinal%2BChemistry%2Band%2BBiology%2BPerspective%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D3%26spage%3D1197%26epage%3D1210%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291631" title="Modulators">Modulators</a>,</li><li><a href="/action/doSearch?ConceptID=291033" title="Filtration">Filtration</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jmcmar.2013.56.issue-3/production/jmcmar.2013.56.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0014.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The traditional drug discovery strategy of pursuing “one compound–one target” has had difficulties delivering novel therapies for complex diseases currently lacking adequate treatments. An alternative and complementary approach is the design of multitargeted modulators simultaneously addressing multiple pathological mechanisms or overcoming pathway robustness. In this study, we propose a methodology to increase the probability of success for developing dual-acting modulators by systematically and rationally evaluating all dual-acting modulator opportunities within a specific disease area. This approach employs a combination of a five-step medicinal chemistry evaluation and a two-step biological analysis to help select the optimal target combination. It provides a novel methodology suitable for widespread application across disease areas. To exemplify the power of this approach, we focus on an analysis of the gastrointestinal (GI) disease area to identify opportunities supported by current literature data.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery and development of new chemical entities is a high risk, high cost process. It is estimated that it can cost more than a billion U.S. dollars to bring a drug to the market.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This large cost is clearly unsustainable; thus, cost reduction is of the highest priority for everyone working within drug discovery and development. From an efficacy perspective, it is becoming increasingly apparent that it is often insufficient to modulate a single target in isolation to effectively address disease progression. To illustrate this way of thinking, the term network pharmacology has been established.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This approach highlights that targets and pathways rarely act in isolation; rather there exist numerous feedback loops and interconnections that might render a single molecule/single target approach unsuccessful because of pathway redundancies. By analyzing the Drugbank database,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Vidal et al. demonstrated that although successful drugs developed since the advent of the molecular revolution have been targeted against a single molecular entity, they do in fact demonstrate a level of promiscuity that could influence both efficacy and safety.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Indeed, by use of the same database, it was demonstrated that drugs developed to target a single molecular entity are on average active against 1.7 proteins. However, if the bioactivities reported in the literature as well as predicted bioactivities are taken into account, the number climbs to 6.3.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> For example, angiotensin II receptor type 1 is the primary target of telmisartan. However, telmisartan has also been shown to modulate the peroxisome proliferator-activated receptor γ (PPAR-γ) receptor,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> which has been suggested to explain the improved insulin sensitivity with telmisartan treatment that is not evident in other more selective angiotensin receptor antagonists.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">In many of the cited examples, the modulation of multiple targets has been unintentional, and clearly this type of approach presents challenges not only in effectively optimizing  the activities for the selected targets but also in simultaneously optimizing all the ADME properties necessary to develop the dual acting molecule into a successful drug. However, despite these considerable challenges, several success stories have recently been reported in the literature.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> In fact, multitarget drugs are now common in the treatment of neurodegenerative diseases<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and additional successful examples have also been published for depression, hypertension, oncology, inflammation, and diabetes.<a onclick="showRef(event, 'ref9 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref12 ref13">(9, 12, 13)</a></div><div class="NLM_p">In recent years, there has been tremendous progress in the availability of data in both the medicinal chemistry and biology disciplines that can be interrogated through increasingly sophisticated cheminformatics and bioinformatics tools. A variety of public and commercial databases exist that are suitable for data mining: PubChem,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> a public repository of screening data; Chembl,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> a database of manually curated activity data extracted from the biomedical literature; BioPrint,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> a commercial database of screening results for a set of drugs and other pharmacologically relevant substances against a panel of targets; Drugbank,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> a public database combining detailed drug data with drug target information. There are also commercial databases with activity data extracted from journals and patents.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In combination, these resources provide access to an unprecedented amount of data associating compounds to biological activities and have made it feasible to develop a more rational approach to drug discovery than was previously possible. In the same way, more and more data, such as for protein–protein interactions or gene expression, are available to study the biology associated with proteins. Additionally, modern text mining approaches can add further value by extracting detailed compound–target relationships from the wealth of publically available biomedical literature. Recently, a number of studies have been published demonstrating the ability to connect all this information into a coherent system.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a></div><div class="NLM_p last">The combination of the knowledge that most drugs modulate more than one target and the increased availability of relevant chemical and biological information prompted us to develop a methodology to combine both medicinal chemistry and biological information in order to systematically evaluate all possible dual modulators within a specific disease area. A modulator in this context can be an inhibitor, a blocker, an agonist, an antagonist, or a positive/negative allosteric modulator. The methodology includes five medicinal chemistry workflows (MCWs) to help estimate the chemical feasibility of a dual modulator approach and two biology workflows (BWs) for a mechanistic evaluation of opportunities. The workflows, which are general, can be applied to any disease area and have been built to display chemical relationships and information extracted from internal and external data sets in an efficient manner allowing the rapid identification of dual-acting modulator opportunities. With the GI disease area as an example, the value of this methodology to support robust decision making is highlighted.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Application of the MCWs To Explore Dual-Acting Modulator Opportunities within the GI Disease Area</h3><div class="NLM_p">The five MCWs in our methodology are presented in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. They are generated separately and display complementary information to each other. However, when combined, they provide a thorough overview of the suitability for each target combination as a starting point for the discovery and development of a rationally designed dual-acting modulator. In this study, we illustrate the application of the proposed workflow to a set of targets linked to GI diseases and highlight specific opportunities for dual-acting modulators within this disease area. Examples of dual-target modulators (small molecules and peptides) identified through the workflow will be presented. However, it should be noted that examples presented here are all already known and the data available in the public domain. The targets used in the investigation of the GI disease area are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, each of which has previously been associated with GI diseases in the literature. The Entrez Gene identifier<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was used as a handle to extract the activity data from the GoStar<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and BioPrint databases. In all the evaluations, three different activity cut-offs were used, 10 μM, 1 μM, and 100 nM (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). The number of extracted molecules from the GoStar and BioPrint databases using a threshold of 10 μM is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The heat maps obtained from the workflows for our GI example is displayed in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overview of the MCWs and the BWs. For a list of targets associated with a specific disease area, the MCWs are first applied (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). This set of analyses aims to estimate the feasibility of designing a dual-acting modulator for each possible pair of targets within the disease area from a medicinal chemistry perspective. The most interesting target pairs identified in the MCWs and the first BW are thereafter evaluated in the second BW (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). This workflow is target-centric and aims to improve understanding of the mechanistic overlap for each of the target pairs. Finally, the most promising target pairs from the MCWs and the BWs are further evaluated as potential candidates for starting a new drug discovery project.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Heat maps displaying the results from the MCWs (A–E) and the first BW (F). (A) Number of published studies reporting having activities for the same molecule on both targets. Note that CCR9 is not displayed in part A, since there are no recorded publications with dual-acting modulators of CCR9 and any other of the targets in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. (B) Number of known identical or similar compounds acting on both targets, including activity data for the targets from the same publication and when the activity data have been reported for identical (or similar) molecules in different publications. Data were flattened to a maximum of 100, and a white spot indicates that there are no known dual modulators for the targets; however, similar active compounds exist. (C) Number of compounds available for testing each potential hypothesis in an in vivo model. The compounds can be dual modulators and/or only active on one of the targets but can then be used in combination with another tool compound (also accessible from this interface) to test the hypothesis. Data were flattened to a maximum of 100. A star indicates the existence of dual modulators. A circle indicates that no dual modulator is available but tool compounds are available to test the hypothesis with a combination. (D) Overlap of the physicochemical properties between the molecules binding to the two targets (heavy atom count, ionization state, AlogP). The map shows the minimum value of those three overlaps. (E) Number of privileged substructures in common for the active molecules binding to the two different targets. (F) Number of text mining results for combination studies. For the parts A–E, the activity threshold is 1 μM, and “normal” filtering is applied; i.e., compounds from patents without reported biological activity given for the reported targets are included.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. List of the Targets Related to the GI Disease Area under Investigation<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">no. of extracted molecules<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Entrez Gene ID</th><th class="colsep0 rowsep0" align="center">short name</th><th class="colsep0 rowsep0" align="center">full name</th><th class="colsep0 rowsep0" align="center">GoStar</th><th class="colsep0 rowsep0" align="center">BioPrint</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">886</td><td class="colsep0 rowsep0" align="left">CCK1</td><td class="colsep0 rowsep0" align="left">cholecystokinin A receptor</td><td class="colsep0 rowsep0" align="left">8499</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">887</td><td class="colsep0 rowsep0" align="left">CCK2</td><td class="colsep0 rowsep0" align="left">cholecystokinin B receptor</td><td class="colsep0 rowsep0" align="left">10131</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1128</td><td class="colsep0 rowsep0" align="left">CHRM1</td><td class="colsep0 rowsep0" align="left">cholinergic receptor, muscarinic 1</td><td class="colsep0 rowsep0" align="left">18958</td><td class="colsep0 rowsep0" align="left">351</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1131</td><td class="colsep0 rowsep0" align="left">CHRM3</td><td class="colsep0 rowsep0" align="left">muscarinic M3 receptor</td><td class="colsep0 rowsep0" align="left">21424</td><td class="colsep0 rowsep0" align="left">234</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1813</td><td class="colsep0 rowsep0" align="left">DRD2</td><td class="colsep0 rowsep0" align="left">D2 dopamine receptor</td><td class="colsep0 rowsep0" align="left">44646</td><td class="colsep0 rowsep0" align="left">384</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2550</td><td class="colsep0 rowsep0" align="left">GABA-B</td><td class="colsep0 rowsep0" align="left">γ-aminobutyric acid (GABA) B receptor, 1</td><td class="colsep0 rowsep0" align="left">374</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2693</td><td class="colsep0 rowsep0" align="left">GHSR</td><td class="colsep0 rowsep0" align="left">ghrelin receptor</td><td class="colsep0 rowsep0" align="left">6502</td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2862</td><td class="colsep0 rowsep0" align="left">MLNR</td><td class="colsep0 rowsep0" align="left">motilin receptor</td><td class="colsep0 rowsep0" align="left">2123</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2915</td><td class="colsep0 rowsep0" align="left">mGluR5</td><td class="colsep0 rowsep0" align="left">glutamate receptor, metabotropic 5</td><td class="colsep0 rowsep0" align="left">18306</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3274</td><td class="colsep0 rowsep0" align="left">HRH2</td><td class="colsep0 rowsep0" align="left">histamine 2 receptor</td><td class="colsep0 rowsep0" align="left">14380</td><td class="colsep0 rowsep0" align="left">342</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3359</td><td class="colsep0 rowsep0" align="left">5HT3</td><td class="colsep0 rowsep0" align="left">5-hydroxytryptamine (serotonin) receptor 3A</td><td class="colsep0 rowsep0" align="left">1258</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3360</td><td class="colsep0 rowsep0" align="left">5HT4</td><td class="colsep0 rowsep0" align="left">5-hydroxytryptamine (serotonin) receptor 4</td><td class="colsep0 rowsep0" align="left">6170</td><td class="colsep0 rowsep0" align="left">173</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4986</td><td class="colsep0 rowsep0" align="left">KOR</td><td class="colsep0 rowsep0" align="left">κ opioid receptor</td><td class="colsep0 rowsep0" align="left">20276</td><td class="colsep0 rowsep0" align="left">318</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4988</td><td class="colsep0 rowsep0" align="left">MOR</td><td class="colsep0 rowsep0" align="left">opioid receptor, μ1</td><td class="colsep0 rowsep0" align="left">33432</td><td class="colsep0 rowsep0" align="left">265</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5024</td><td class="colsep0 rowsep0" align="left">P2X3</td><td class="colsep0 rowsep0" align="left">purinergic receptor P2X ligand-gated ion channel 3</td><td class="colsep0 rowsep0" align="left">4471</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6865</td><td class="colsep0 rowsep0" align="left">NK2R</td><td class="colsep0 rowsep0" align="left">tachykinin receptor 2</td><td class="colsep0 rowsep0" align="left">15185</td><td class="colsep0 rowsep0" align="left">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6869</td><td class="colsep0 rowsep0" align="left">NK1R</td><td class="colsep0 rowsep0" align="left">tachykinin receptor 1</td><td class="colsep0 rowsep0" align="left">29179</td><td class="colsep0 rowsep0" align="left">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7166</td><td class="colsep0 rowsep0" align="left">TPH1</td><td class="colsep0 rowsep0" align="left">tryptophan hydroxylase 1</td><td class="colsep0 rowsep0" align="left">433</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7442</td><td class="colsep0 rowsep0" align="left">TRPV1</td><td class="colsep0 rowsep0" align="left">transient receptor potential cation channel, subfamily V,member 1</td><td class="colsep0 rowsep0" align="left">26863</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10803</td><td class="colsep0 rowsep0" align="left">CCR9</td><td class="colsep0 rowsep0" align="left">chemokine (C–C motif) receptor 9</td><td class="colsep0 rowsep0" align="left">1635</td><td class="colsep0 rowsep0" align="left">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">The “normal” option for filtering the compounds from GoStar has been used (activity threshold, 10 μM); i.e. patents that do not have explicit activity data recorded for the targets in the patents are also included in the analysis.</p></div></div></div><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A presents the outcome from MCW 1 applied to the GI target set. Initially the GoStar database was used to identify target combinations for which there was pre-existing literature evidence for dual-acting modulators. The heat map generated highlights the existence of any previously published information across the range of the chosen dual-acting opportunities. It is not distinguished in the analysis whether the dual-acting modulator is designed to be dual-acting or whether the activity at one of the targets was considered to represent an off-target effect. As might be expected, the second case is quite common for two targets that have a high sequence similarity. For instance, there are a number of published structures that exhibit dual-target activity for highly similar sequences, for example, the cholecystokinin A receptor and cholecystokinin B receptor (CCK1 and CCK2) and the muscarinic M1 receptor and muscarinic M3 receptor (CHRM1 and CHRM3) target combinations (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A,B and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sequence similarity between the protein sequences of the targets. Protein sequence alignments were calculated with ClustalW using default parameters.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The heat map shows the percentage of identity between each protein sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">MCW 2 extends the initial analysis to include data where the activities for the different targets have been reported in different publications for a compound (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). A general observation is that the heat map is much more populated in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B than in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A. This is due to the same compound having been reported to have activity against more than one target relevant for the disease area. However, these occurrences may arise across a number of different sources and the dual-activity might therefore not necessarily be noticed. This is an important aspect in future prioritization of opportunities, and if more and additionally structurally diverse, dual-acting modulators are known for a target combination, it is assumed to be easier to develop a novel dual-acting modulator with high-quality druglike properties. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B also highlights situations where there is an absence of characterized dual modulators for a given target combination but where structurally similar compounds do exist for each of the individual targets. An example is the chemokine (C–C motif) receptor 9 (CCR9). In this case there are no known dual-acting modulators for CCR9 and any of the other targets analyzed for the GI disease area. However, identified compounds do exist that are active on CCR9 and that have similarity to compounds active on other targets in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (e.g., CCK2 and the purinergic receptor P2X, ligand-gated ion channel 3 (P2X3)). Furthermore this analysis highlights the existence of a number of compounds that modulate greater than two targets, highlighting the requirement to carefully examine the activity profile for each molecule individually. This can be achieved through drilling down of the displayed data via a set of Web interfaces to display all biological activities for each molecule. Finally, it is also sometimes useful to display the difference between the workflows 2 and 1 to emphasize the potential dual-acting modulator opportunities for which there is no previous publication describing molecules with activities against both targets in the same publication.</div><div class="NLM_p">The third MCW (MCW 3) is designed to identify opportunities to validate a target combination in vivo.For this task, only approved drugs and clinical candidates were extracted from BioPrint and GoStar databases. These compounds are most likely to have suitable ADME properties for preclinical in vivo experiments and therefore represent optimal tool compounds to effectively validate a given target combination. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C presents any such opportunities identified from within the GI disease area. A circle highlights target pairs suitable for testing in combination type in vivo experiments, whereas the availability of a dual-acting drug or clinical candidate for a target combination is indicated by a star. We have purposely designed Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C to be asymmetrical in order to specifically highlight the number of compounds that are available for each of the chosen target pairs. The number of active compounds for each of the two targets is shown through the color and size of the dot. For targets on the horizontal axis, the number of active compounds is shown through the color, and for targets on the vertical axis the number of compounds available is shown through the size of the dot. The data displayed for an activity threshold of 100 nM are especially interesting, since these compounds have a high probability of demonstrating an effect in a relevant in vivo model. The availability of a dual-acting modulator is not necessary for the validation of an additive or synergistic effect for the target combination, as the hypothesis can be validated through a combination of two different compounds with good enough potency and selectivity, ADME, and pharmacokinetic/pharmacodynamic (PK/PD) profile for one of the two targets each. It is important to investigate the selectivity profile of the compounds used in the in vivo experiment. Preferably the selected dual-acting modulator (or the two different modulators, one for each target) should have a good selectivity profile against other targets so that there is confidence that the observed in vivo effect is due to the modulation of the two targets of interest and not an off-target effect. Here, only data from the BioPrint and GoStar databases are displayed; however, these data can be supplemented by other internal and external sources.</div><div class="NLM_p">An analysis of bioactivity data indicates that multiple acting modulators tend to be more lipophilic and somewhat larger than more selective compounds.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This phenomenon has been referred to as the “physicochemical challenge” in designing dual-acting modulators. Therefore, our interest primarily focused on dual-acting modulator opportunities where the extent of molecular framework integration is maximized while avoiding compromises on physicochemical properties and oral bioavailability. Along these lines, MCW 4 was designed to indirectly estimate the similarity of the binding cavities through combined analysis of the physicochemical properties of known modulators for each of the targets. It will be more straightforward to develop a dual-acting modulator if the binding cavities are similar for the target combination for which there is an intention to develop the dual-acting modulator. The binding cavity similarity can be measured in two different ways, either directly by comparing the cavities to which the molecule binds or indirectly by comparing the properties of the molecules that bind to each cavity. The direct method would be preferred if the X-ray crystal structure is known for all the targets of interest. However, with the possible exception of the infection and oncology disease areas, it is unrealistic to expect crystal structures of all the targets under investigation to be available within a disease area. Therefore, as MCW 4, we have chosen to compare the binding cavities indirectly through comparison of the known modulators that bind to each of the targets. In a recent study, it was proposed that there are three fundamental properties of a molecule: size, lipophilicity, and ionization state.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D presents the overlap of the distributions of the three physicochemical properties for the active molecules on each target as an indirect estimate of the similarity of the binding cavities. To aid visual inspection of the outcome of this analysis, the color of the dot reflects the overlap of the property that has the smallest overlap between the active compounds for the two targets. The shape indicates which property has the lowest overlap. By way of an illustration, the overlap between the active compounds for the ghrelin and motilin receptors (GHSR and MLNR) is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Inspection of the analysis presented for these targets in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D suggests only medium overlap for at least one of the physicochemical properties, and the shape indicates that the overlap is lowest for the size. Drilling down provides further evidence that the overlap of both the lipophilicity and the ionization state is high while it is only medium with respect to the size.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Physicochemical property distributions for the active compounds of MLNR and GHSR. Activity threshold was 1 μM, and “normal” filtering is as described in the text. The heavy atom count distribution has been truncated at 75 to remove large peptides. This view is extracted for the Web interface associated with the MCW 4 and enabled drill down to more detailed data than the heat map alone for each pair of targets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The final MCW (MCW 5) presents an analysis of the number of privileged fragments in common for each target combination (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>E). While it is considered beneficial if targets already possess robust molecules suitable for developing a dual-acting modulator, in many circumstances this may not be available. However, even in the absence of structurally similar molecules for a target combination it is of value to understand if the targets possess common privileged fragments. The presence of common privileged fragments identifies future opportunities to design chemical libraries with the intention of exploring novel chemical space and driving the synthesis of novel dual-acting modulators.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a> Moreover, an already known chemical equity might not be an optimal starting point for further exploitation. In this case, it might be very helpful to investigate if all the known active compounds on target A and all the known active compounds on target B have any privileged fragments in common. The number of privileged fragments for each target combination is displayed in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>E. There exist privileged fragments for many of the target combinations, so at least for these cases there could be opportunities to design chemical libraries with the intention of exploring novel chemical space and identifying novel dual-acting modulators. Explicit examples of privileged fragments are given later in this section for the GHSR/MLNR combination.</div><div class="NLM_p last">As a further addition to the medicinal chemistry analysis, we have we also included the potential to apply additional filtering criteria to the results: a “strict” option excluding data from patent(s) with no explicit reported activity data and a “normal” option including this data (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). A significant difference is observed between the two filtering methods. For example, by incorporation of an activity threshold of 10 μM, the “strict” way of filtering (excluding patents with no explicit activity data) extracted a total of 105 576 different compounds; whereas the “normal” filtering option retrieved 217 650 compounds. A consequence of these differences is the possibility of identifying increased numbers of target pairs with the “normal” way of filtering. Applying this approach to MCW 1 at 10 μM demonstrates the identification of 70 pairs of targets using the “normal” way of filtering compared with 61 through application of the “strict” filtering approach out of the 190 target pairs for the set of used GI targets. In the same way, at 1 μM, 64 pairs are identified as having dual modulators with the “normal” filtering (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) whereas 48 are identified with the “strict” filtering. Given these findings, we advocated beginning with the “strict” filtering option which generates an output of increased confidence but with the caveat that some compounds might have been missed. As a second step, the results can subsequently be expanded using the “normal” filtering, where all available data are accessible but might contain more false positives.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Application of the BWs To Explore Dual-Acting Modulator Opportunities with the GI Disease Area</h3><div class="NLM_p">Not all information important for identifying new target combinations suitable for the development of dual-acting modulators resides in bioactive compound databases. The biology perspective of our approach focuses on both developing and strengthening the biological rationale for modulating two targets in conjunction, either through a dual-modulator approach or via coadministration of compounds selective for the individual targets combination (i.e., a combination treatment). There are two separate BWs: text mining and bioprocess mapping.</div><div class="NLM_p">The first BW (BW 1, text mining) is complementary with MCW 1: they both investigate the precedence of known literature studies on relevant target combinations. However, whereas MCW 1 identifies published dual-acting modulators, BW 1 focuses on applying text mining approaches to extract published information on combination therapies, previously identified functional synergies, and separate studies investigating both targets (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for more details). Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>F presents the output of BW 1 as applied to the GI target set and displays the numbers of documents identified through text mining defined as relevant for the specific evaluation. For the GI targets we found that there exist relevant documents for 83 of the 190 target pairs, with 71 pairs having greater than 10 text mining hits. This compares well to the 64 pairs of potential dual modulators identified through the first MCW using an activity threshold of 1 μM. A total of 33 overlapping target pairs were identified by both processes. Some examples from the analysis of the GHSR/MLNR combination are discussed in more detail below (see <a class="ref internalNav" href="#sec2_3" aria-label="Example 1">Example 1</a>).</div><div class="NLM_p">The second BW (BW 2, bioprocess mapping) aims to provide a mechanistic overview of the impact of modulating the two targets in combination. This approach maps the impact of modulating each target individually or both targets in combination at the pathway level, the intracellular and macrocellular levels, the pathophysiology level, and finally the disease level. Both GeneGO MetaCore<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and Ingenuity IPA (Ingenuity Systems, <a href="http://www.ingenuity.com" class="extLink">www.ingenuity.com</a>) databases provide rich data for many targets at the first two levels, i.e., pathway and intracellular processes. However, to enable a full interpretation of the potential clinical impact of modulating key targets, literature mining is also used to further link the targets to the pathophysiology and primary disease processes. Any gaps in the network maps are filled in an iterative process in a close collaboration with the disease area biology experts. By taking a multilevel view, key similarities and differences between the two mechanisms of action can be readily highlighted. This detailed approach provides an opportunity to develop a comprehensive overview of the predicted role targets may play in disease mechanisms and the consequences of targeting them with dual-acting modulators. For example, the use of common intracellular pathways may indicate potential opportunities to overcome redundancy seen for single targets or the modulation of pathophysiology via two distinct biological processes (and in some cases present in distinct organs), which may further strengthen an argument for dual modulation.</div><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> highlights an example of detailed bioprocess mapping for the GI target pair of NK1R and μ-opioid receptor (also discussed later in this section). The map highlights how both targets affect GI motility and abdominal pain. This task is manually intensive and highly time-consuming; therefore, it is only carried out for the most relevant target pairs identified using the five MCWs and the BW1. It is, however, considered that for key target combinations this is time well spent and the developed network maps have a number of benefits to projects and organizations from supporting decision-making to effective information and data-sharing.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Bioprocess map summarizing the literature knowledge for the biological roles of the NK1 receptor and MOR. A bioprocess map is built in the context of the second task of the BW (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Data 3">Supporting Information Data 3</a> for the PMID of the publications used). Such maps are used to asses if a biological rationale for modulating two targets in conjunction exists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Example 1: Dual Ghrelin and Motilin Receptor Opportunities Identified from the Workflows</h3><div class="NLM_p">With the help of the MCWs, a series of small molecule based opportunities was identified with GHSR being one of the components of a dual-acting modulator (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). It is perhaps not particularly surprising that MLNR is identified as one of the preferred combinations with GHSR, considering that the endogenous precursor peptides of GHSR and MLNR share almost 50% sequence similarity in their amino acid sequence.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The receptors also form part of the same subfamily of G-protein-coupled receptors and share 53% overall amino acid sequence identity. Furthermore, both peptides have been demonstrated to play an important role in GI motility regulating the interdigestive migrating contractions (IMC) resulting in prokinetic effects.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> This is supported by the data generated from BW 1 in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>F which clearly demonstrates that for the GHSR the combination with motilin presents the greatest level of biological validation. Approaching this question the other way, however, by starting with motilin also predicts the involvement of other key targets including 5-HT3, 5-HT4, and dopamine D2 receptors. By combination of this level of biological information to strengthen the biological rationale for identifying dual-acting molecules with the MCW, it is more straightforward to identify and prioritize future opportunities for dual-modulator approaches. A number of examples of dual-acting MLNR and GHSR modulators can be identified from the heat map shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B (see Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> for examples).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Examples of dual-acting MLNR and GHSR modulators. The top part of the figure is a section of the heat map from the second MCW identifying dual-acting compounds or similar compounds active on one target each (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). The data were flattened to a maximum of 100. A white circle indicates that there is no dual-acting modulator known for the target pair; however, similar compounds exist that are active on one target each. The activity threshold was set to 100 nM and with the “normal” filtering option as described in the text. A privileged fragment is highlighted in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For example, the dual acting benzazepine sulfonamides were discovered by a high-throughput screen against the MLNR.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Further, structural modifications highlighted that the activity at both receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) can be comodulated as well as tuned toward a selective orally bioavailable MLNR agonist. While the developability toward selective dual-acting modulators still needs to be further evaluated, the available structure–activity relationship (SAR) data provide an early insight into the opportunities and risks aligned with the benzazepine series in this context.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Additionally, this series highlights the ease with which existing chemical equity in the literature can be scrutinized in the MCWs. Indeed and not surprisingly, as displayed in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, the active compounds of the GHSR and the MLNR share similar physicochemical properties (size, lipophilicity, and ionization state; MCW 4). The lipophilicity and ionization states of the active compounds are very similar for MLNR and GHSR, while the active compounds on the MLNR receptor are larger than the active molecules on the GHSR receptor. Therefore, from a physicochemical perspective the challenge to develop a dual-acting modulator will be mainly from a size perspective. Further analysis of the data sets highlights that many ligands acting on the GHSR and MLNR receptors share common substructural elements such as a benzazepine residue as displayed in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>. The outlined workflow MCW 3 allows the identification of tool compounds suitable for in vivo/in vitro target validation work. Compounds such as MA-2029, GM-611, and ibutamoren were easily identified as tools for the GHSR and MLNR (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Examples of tool compounds found with MCW 3 for MLNR and GHSR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Benzazepinesulfonamide Type Dual-Acting Modulators Active on MLNR and GHSR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0011.gif" alt="" id="fx2" /></img><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Example 2: Dual NK1–Opioid Receptor Opportunities</h3><div class="NLM_p">A second example identified through the application of this process within the GI disease area is dual-acting neurokinin type 1 (NK1) and μ-opioid receptor modulators. Opioids are the most widely used analgesics, and the effects of compounds acting directly at the G-protein-coupled μ-opioid receptor (MOR) have been well documented.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, the clinical treatment of pain, and particularly chronic neuropathic pain, remains a major challenge due to tolerance, physical dependence, and the limited access of many compounds to the CNS. In contrast, the G-protein-coupled receptor NK1 preferentially binds substance P, a peptide belonging to the tachykinin family that was originally discovered based on its ability to regulate intestinal motility, secretion, and vascular function in the gut.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Recent evidence has emerged for the biological interaction between the opioid and neurokinin systems at a number of different levels that have been captured using a bioprocess mapping approach as demonstrated in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. For example, MORs are coexpressed with NK1 receptors in the CNS and initial observations demonstrated that chronic opioid treatment results in the release of substance P and up-regulation of its receptor NK1. Furthermore, NK1 receptor knockout mice were largely protected from opioid-induced tolerance, and these findings have been further extended through clinical studies combining aprepitant, a clinically marketed NK1 selective antagonist, with opioid agonists to modulate the response to oxycodone in prescription opioid abusers.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> These data have led to the suggestion that compounds exhibiting both MOR modulatory efficacy and NK1 receptor antagonist efficacy may offer the opportunity to address some of the undesirable side effects of current opioid-based therapies.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a></div><div class="NLM_p">The MCWs highlighted a series of NK1 antagonists that where selective against a panel of 14 other GPCRs.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> However, they also highlighted that the compounds share significant μ-opioid receptor activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The SAR studies outlined in the work point toward the potential of the development of high affinity dual-acting modulators. In general, a monosubstitution on the aniline phenyl ring was shown to be slightly favorable with respect to μ-opioid affinity, and additionally replacing the isopropylidene moiety by other small groups (cyclopropyl) also improved the affinity on the μ-opioid receptor.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Compounds from DeNanteuil et al. Displaying a Dual Activity against the NK1 Receptor and MOR<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0013.gif" alt="" id="fx4" /></img><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Example 3: Dual Opioid–CCK Receptor Opportunities</h3><div class="NLM_p">Finally, although the primary focus for this study was on the identification of dual-acting small molecule compounds, the design of bispecific peptides has seen significant attention during the past few years, especially in the area of diabetes. However, one needs to keep in mind that the data sets used for the analysis are less rich for peptides compared to small molecules. So to further demonstrate the utility of our approach, the MCWs were used to identify known bispecific peptides based on overlapping privileged substructures (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>E). Two examples are illustrated below. Hruby et al. designed novel peptides based on overlapping pharmacophores of the opioid and the cholecystokinin (CCK) endogenous peptides.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The novel peptides incorporate the opioid pharmacophores in the N-terminus and the CCK tetrapeptide pharmacophores in the C-terminus of the novel peptides (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). The designed peptides interact with δ (and/or μ) opioid receptors as agonists and with CCK1 and CCK2 receptors as antagonists based on the concept that the pain-relieving actions of the opiates may be limited by the pronociceptive and antiopiate actions of CCK8. The pharmacological action of these peptides was not further evaluated in pain models; however, their results highlight the utility of designing overlapping pharmacophores of two peptides into a single peptide as a valid drug design approach. A similar strategy has been taken by Kream et al. for the design of tachykinin substance P and opioid dual acting peptides.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Overlapping functional NH<sub>2</sub>- and COOH-terminal functional domains of the endogenous opioid endomorphin-2 and the tachykinin SP formed the basis for the development of chimeric peptide ESP-7 (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) which demonstrated a unique non-tolerance-forming analgesic effect.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Dual-acting opioid/CCK and opioid/NK1 peptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64244" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64244" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this article, a methodology combining medicinal chemistry and biology workflows to systematically explore dual-acting modulator opportunities within a disease area has been proposed. The workflows presented integrated information in a common framework and display the information in an efficient way for the end users. Additionally, they can help identify already available dual-acting tool modulators, which allows for rapid in vivo (preclinical proof-of-principle) concept testing. They are a first step toward a strategy that will be complementary to current, more target-centric views.</div><div class="NLM_p">The intention in this study is to identify, in a comprehensive way, opportunities in medicinal chemistry to provide compounds that will modulate the activity of pharmacological systems rather than focusing purely on a single target activity. Through evaluation of all target combinations and all known chemical equity, the most appropriate dual-acting scaffold type can be identified and progressed. The goal of the presented MCWs is to find molecular structures that satisfy the basic pharmacophoric requirements of each target within an acceptable physicochemical property space. In our opinion, this needs to be combined with a detailed understanding of the role of each target in pathophysiological mechanisms in order to help prioritize the rational design of dual-acting modulators. This medicinal chemistry evaluation is supported by the biological workflows that provide an early insight into target pathways and their relationships for a specific target combination. Consequently, the analysis can be viewed as a “chemical biology” approach for designing dual-acting modulators.</div><div class="NLM_p">To illustrate and validate the power of the developed workflows, we have drawn upon previously described small molecule and peptide examples from the GI disease area. The intention of this study is not only to illustrate the workflow applied to a set of targets linked to GI diseases and to highlight specific opportunities for dual-acting modulators within this disease area but also to demonstrate the general applicability of this approach suitable for any disease area. An interesting future model might be to combine fragment based screening with the design of dual-acting modulators.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In this context, the fifth chemistry workflow comparing privileged ligand substructures between targets could provide relevant seeds for fragment based screening.</div><div class="NLM_p last">It is emphasized that there are many further considerations such as peripheral vs central acting molecules, PK/PD relationships, and route of administration that need to be part of the feasibility assessment of dual-acting modulators. However, in this study, discussions regarding PK/PD are considered to be out of scope. We believe that these potential concerns require addressing on a case-by-case basis depending on the time scale needed to for the therapeutic effect. The rational design of molecules that simultaneously modulate different proteins, either positively or negatively, at comparable concentrations for each of the targets remains a challenging task. In many instances, further experimental assessment will be required to develop a deeper insight into the developability of these individual dual-acting modulators. The proposed analysis provides additional insight in intragene and intergene relationships, which allows for lead generation activities utilizing the SOSA (selective optimization of side activities) concept or identification of potential risks of undesired side effects within specific indication areas due to lack of selectivity.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> For example, the documented intragene relationship of monoaminergic and peptidergic G-protein-coupled receptor (GPCR) modulators is also observed in the analysis of the GI target list. This represents a previously known relationship that has been used for developing new selective modulators for peptidergic GPCRs.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In the same way, an issue raised in the literature concerns dual modulator molecules being too large to be orally available. This particularly can be the case if a specific target combination is selected as the first step in the project. In this case, the receptor cavities for the two targets might be dissimilar. This might lead to the design of a too large dual-acting modulator, which, because of a large polar surface area (PSA), would have limited adsorption into the bloodstream. The intention of the careful analysis of all target pair combination presented here is to avoid selecting a target combination that because of mismatches in the binding cavities will lead to too large a compound during the optimization stage. The proposed workflow is mainly applicable for the development of novel orally available drug candidates. If other administration routes are possible or even preferred, it might be easier to develop a dual-acting modulator by connecting the two molecules with the help of a linker. In the end, opportunities within a disease area for dual-acting modulators need to be assessed versus single molecule–single target options and the prospects for combining two molecules modulating two different targets into one formulation. However, the feasibility of designing dual-acting modulators has been demonstrated and the lists of examples are growing constantly.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Some very recent examples in the literature are the design of dual-acting melanin-concentrating hormone receptor (MCHR1) antagonists or G-protein-coupled receptor 119 (GPR119) agonists that also show dipeptidyl peptidase 4 (DPP-IV) inhibition.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A novel workflow to identify opportunities for rationally designing dual-acting modulators has been proposed. The workflow aims to exploit all possibilities within a disease area to identify opportunities that avoid designing dual-acting modulators with poor physicochemical properties. Historically, the design of multiple acting modulators has had issues with combining good physicochemical properties of the modulator with high potencies on both targets. It is hoped that a thorough evaluation of all possible target combinations will improve the odds of identifying highly potent dual-acting modulators with good physicochemical properties. Examples are given here for targets involved in GI diseases. The GI disease area is an area with high unmet medical needs, and our analysis indicates that rational design of dual-acting modulators might be a feasible approach to identify novel treatments. The workflows in themselves do not make novel predictions of suitable target combinations. Instead the workflows collect all available relevant data and display the data in such a way that a user can very efficiently view all options and decide which options that should be prioritized for further validation in either in vitro or in vivo disease models.</div><div class="NLM_p last">A thorough investigation of all possible target combinations to identify the best options from both a chemical and a biological perspective is, to our knowledge, a novel way of exploiting existing knowledge to create new drug discovery projects. In conclusion, it is proposed that evaluating both medicinal chemistry and biology aspects systematically for all target combinations within a disease area can lead to more successful drug discovery and development projects.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14126" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14126" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Medicinal Chemistry Data Resources</h3><div class="NLM_p last">All data were extracted and filtered with Pipeline Pilot.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The resulting heat maps from the data processing were displayed in TIBCO Spotfire Decision site.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Activity data were extracted from the GoStar<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the BioPrint<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> databases. The Entrez Gene identifier was used to extract all active compounds for a given set of targets relevant for the investigated disease area. The information was filtered, and only dose–response activity data were used from GoStar. The data were extracted and analyzed for three different activity cut-offs, 100 nM, 1 μM, and 10 μM. However, in many patents, activity data are not included. It was therefore decided to have a “strict” option alternative, where all the data from patents without activity data were excluded, and a “normal” option when the data were included. Thus, for all the MCWs there are six alternatives based on the three activity cut-offs and the “strict” option for displaying the data. In BioPrint, the assays were manually mapped to Entrez Gene identifiers and all active compounds for a set of Entrez Gene identifiers were extracted. The extracted data from the BioPrint database were also included in the analysis at the three activity cut-offs 100 nM, 1 μM, and 10 μM. Additional sources of bioactivity data like Chembl and PubChem can be easily incorporated.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Medicinal Chemistry Workflows</h3><div class="NLM_p">All the cheminformatics analyses were done within Pipeline Pilot. In order to integrate both BioPrint and GoStar databases, compounds sharing the same canonical SMILES were considered identical.</div><div class="NLM_p">In MCW 1, compounds are extracted from GoStar only. Compounds active on both targets according to the considered threshold are taken into account if the activities have been published in the same article or patent. In MCW 2, extended connectivity fingerprints with a length of 4 (ECFP_4) available in Pipeline Pilot<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> were used for the similarity estimation. The Tanimoto coefficient was used to evaluate the similarity between molecules. Two molecules with a Tanimoto similarity above 0.6 were considered to be similar enough to highlight the possibility of designing a dual-acting modulator for the target combination. In MCW 3, all compounds from BioPrint are taken into account. Compounds extracted from the GoStar database are only included if they originate from the Drug Database or the Clinical Candidate Database. In MCW 4, the heavy atom count was used as a measure of molecular size. AlogP as implemented in Pipeline Pilot was used as a measure for liphophilicity. The ionization state was also calculated with Pipeline Pilot. Finally, for MCW 5, the ECFP of length 6 (ECFP_6) in Pipeline Pilot was used to define the fragments. Each bin in the ECFP_6 fingerprint represents one fragment. The use of ECFP_6 fingerprints in this part of the analysis, compared ECFP_4 previously, is due to ECFP_6 representing larger fragments of a molecule than ECFP_4. ECFP_6 provided more useful fragment information when the restriction to only include fragments with at least two rings was applied. The restriction ensured that the identified fragments would be of a reasonable size and good starting points for library designs. A standard Bayesian analysis as implemented in Pipeline Pilot was thereafter done to calculate the probability for each fingerprint bin in the set of compounds active on a given target and in the whole data set from the GoStar database. A Laplacian corrected estimator was used to account for undersampled fingerprint bins in the Bayesian analysis.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Only fingerprint bins that had 5 times higher frequency among the active compounds for both of the targets in comparison to their frequency in the whole data set were considered to be privileged and accordingly displayed in the MCW 5.</div><div class="NLM_p last">Web interfaces to drill down from each heat map were developed in Pipeline Pilot.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Biology Data Resources and Tools</h3><div class="NLM_p">In order to develop text mining queries, sets of synonyms were extracted and manually curated for the targets of interest, the marketed drugs, and/or the clinical candidates that are known to modulate them. The data source used for extracting the protein synonyms was an in-house repository containing synonyms from the HUGO Gene Nomenclature Committee (HGNC),<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> the VEGA 35 gene set from the Sanger Institute,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Entrez Gene,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Uniprot,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Thomson Pharma,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Thomson Reuters Integrity,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and GoStar. Similarly, the drug synonyms were extracted from an in-house repository containing synonyms from Thomson Pharma, Thomson Reuters Integrity, Adis R&D Insight,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and Citeline Pipeline.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The linkage between the targets and the drugs/clinical candidates was extracted from Thomson Pharma and Thomson Reuters Integrity.</div><div class="NLM_p">The text mining queries were run against an in-house data repository containing abstracts from publications available in Medline<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and Embase,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> conferences from the Knowledge Discovery Platform (MIS KDP),<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Clinical Trials from ClinicalTrials.gov<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and TrialTrove,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> patents from the European Patent Office (EPO, <a href="http://www.epo.org/" class="extLink">http://www.epo.org/</a>), grants from the National Institutes of Health (NIH) Reporter (<a href="http://report.nih.gov/index.aspx" class="extLink">http://report.nih.gov/index.aspx</a>), the Medical Research Council (MRC, <a href="http://www.mrc.ac.uk/index.htm" class="extLink">http://www.mrc.ac.uk/index.htm</a>), and the Biotechnology and Biological Sciences Research Council (BBSRC, <a href="http://www.bbsrc.ac.uk/home/home.aspx" class="extLink">http://www.bbsrc.ac.uk/home/home.aspx</a>), and European Research Council (ERC) grants (<a href="http://erc.europa.eu/" class="extLink">http://erc.europa.eu/</a>). This document repository was searched using the open source search engine Solr.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The search was then refined and annotated using Pipeline Pilot Text Analytics Collection and the open source Peregrine engine.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p last">For the second BW (bioprocess mapping), the GeneGo MetaCore software and the Ingenuity Pathways Analysis platform (IPA) were used as data sources. The literature search was done against Medline.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The maps are visualized in an interactive software program developed in-house (Network Graph Viewer) where evidence supporting each edge is directly accessible.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> The Two BWs</h3><div class="NLM_p">In order to identify combination studies, a set of phrases related to drug/target combinations were manually identified in the literature. A drug in this context can be either a small molecule or a biological drug. Examples of these phrases included are the following: combination therapy, combination of drugs, combined, coadministration, dual modulator, and synergistic effect (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Data 1">Supporting Information Data 1</a> for the complete list of the terms used). In the same way, in order to annotate those studies as relevant or not relevant for the disease area of interest, a set of terms related to the disease area was gathered from the literature. For the GI disease area example, terms included are the following: gastrointestinal, bowel, vomiting, diarrhea, and gastroparesis (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Data 2">Supporting Information Data 2</a> for the complete list of the terms used). Text mining queries were then run against the in-house data source repository described above. Because of the huge diversity of phrases authors employ for describing drug or target combination studies, a “greedy” algorithm was adopted to identify co-occurrences of synonyms for a given protein A (or synonyms of drugs active on A), synonyms for a given protein B, and optionally combination and disease relevant terms for all protein A–protein B combinations.</div><div class="NLM_p">The search for drug–drug combinations takes advantage of the data structure in Thomson Pharma, Adis R&D Insight, and TrialTrove databases and identified combination terms used to annotate the technology employed to develop drugs.</div><div class="NLM_p">The resulting document set is enriched with relevant literature. To provide the opportunity for the end users to effectively filter the generated outputs depending on the disease area and biological mechanisms on which they are focused, this set is then postprocessed to calculate the following:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Number of proteins appearing in a sentence containing the proteins of interest. If the proteins of interest occur among several other protein names, it is reasoned that the study is probably not focused on this specific protein.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Number of times disease terms occur in a sentence that contains the disease of specific interest. In the same way as above, this will be used to filter out studies that are not focused on the disease area of interest.</p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Average minimal distance in the text between the combinations terms and the synonyms for proteins A and B. The smaller the distance is, the more probable the combination term and the protein names are associated.</p></td></tr><tr class="li1"><td valign="top">(4)</td><td colspan="5" valign="top" class="paragraph"><p class="last">A relevance score based on the number of occurrences for each type of term.</p></td></tr></table></div><div class="NLM_p">Moreover, in order to remove duplicated publications from Medline and Embase as well as very similar patents, grants, and congress abstracts submitted across multiple associations or conferences, the Pipeline Pilot text analytics module was used. The abstract and title of each document were represented with a normalized term frequency–inverse document frequency vector (UnitTF-IDF).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> For each word present in the document collection, this vector measures the importance of this word for a specific document relative to its frequency within the collection. The similarity between documents is then calculated as the inner product of these UnitTF-IDF vectors. All documents with a similarity closer than a threshold were clustered together and considered as a single document. An empirical threshold of 0.85 was chosen based on previous experience with this algorithm.</div><div class="NLM_p">The resulting document sets are finally assembled in a single summary as a heat map. In this heat map, the results can be filtered according to all calculated properties described above in addition to data source, publication year, or author. Finally, a Web interface is directly accessible in order to allow the user to interrogate the data in more depth and provide access to the full text documents.</div><div class="NLM_p last">The second BW consists of a pathway analysis integrated to a literature search about the targets mechanisms of actions. GeneGO Metacore, IPA, and literature sources such as Medline are mined and integrated to manually construct internal multiscale networks. The logical linkage between different biological levels is manually investigated (intracellular and macrocellular levels, pathophysiology level, disease level). GeneGO and IPA provide information about the pathways on which the targets have an impact. Complementary annotations in those data sources also provide information about the intracellular and macrocellular impacts of the modulation of the targets or of their pathways in different tissues and species. Linkages between targets and diseases are also accessible. Finally, the logical linkage between the macrocellular levels and the diseases via a pathophysiological level is more challenging to identify and often need manual intensive search of the literature using Medline.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19"><a href="/doi/suppl/10.1021/jm301653f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Lists of terms used for the text mining in the BW 1 and list of PMIDs of the publications used to build the knowledge map in BW 2. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301653f/suppl_file/jm301653f_si_001.pdf">jm301653f_si_001.pdf (70.81 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm301653f" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aurelie Bornot</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences, Computational
Biology, AstraZeneca R&D, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span>; 
    <span class="author-email">
                Email: <a href="mailto:"></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Udo Bauer</span> - <span class="hlFld-Affiliation affiliation">iMED CV/GI, Medicinal Chemistry, AstraZeneca
R&D, Pepparedsleden 1, Mölndal,
SE-431 83, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alastair Brown</span> - <span class="hlFld-Affiliation affiliation">iMED CV/GI, AstraZeneca
R&D, Alderley Park, Macclesfield, Cheshire, SK10
4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mike Firth</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences, Computational
Biology, AstraZeneca R&D, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline Hellawell</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences, Computational
Biology, AstraZeneca R&D, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ola Engkvist</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences,
Computational
Chemistry, AstraZeneca R&D, Pepparedsleden
1, Mölndal, SE-431 83, Sweden</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i20" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i20"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i21" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i21"> Abbreviations Used</h2><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">BBSRC</td><td class="NLM_def"><p class="first last">Biotechnology and Biological Sciences Research Council</p></td></tr><tr><td class="NLM_term">BW</td><td class="NLM_def"><p class="first last">biology workflow</p></td></tr><tr><td class="NLM_term">CCK</td><td class="NLM_def"><p class="first last">cholecystokinin</p></td></tr><tr><td class="NLM_term">CCK1</td><td class="NLM_def"><p class="first last">cholecystokinin A receptor</p></td></tr><tr><td class="NLM_term">CCK2</td><td class="NLM_def"><p class="first last">cholecystokinin B receptor</p></td></tr><tr><td class="NLM_term">CCR9</td><td class="NLM_def"><p class="first last">chemokine (C–C motif) receptor 9</p></td></tr><tr><td class="NLM_term">CHRM1</td><td class="NLM_def"><p class="first last">muscarinic M1 receptor</p></td></tr><tr><td class="NLM_term">CHRM3</td><td class="NLM_def"><p class="first last">muscarinic M3 receptor</p></td></tr><tr><td class="NLM_term">DPP-IV</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase 4</p></td></tr><tr><td class="NLM_term">ECFP</td><td class="NLM_def"><p class="first last">extended connectivity fingerprints</p></td></tr><tr><td class="NLM_term">EPO</td><td class="NLM_def"><p class="first last">European Patent Office</p></td></tr><tr><td class="NLM_term">ERC</td><td class="NLM_def"><p class="first last">European Research Council</p></td></tr><tr><td class="NLM_term">GHSR</td><td class="NLM_def"><p class="first last">ghrelin receptor</p></td></tr><tr><td class="NLM_term">GI</td><td class="NLM_def"><p class="first last">gastrointestinal</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">GPR119</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor 119</p></td></tr><tr><td class="NLM_term">HGNC</td><td class="NLM_def"><p class="first last">HUGO Gene Nomenclature Committee</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">Ingenuity Pathways Analysis</p></td></tr><tr><td class="NLM_term">KDP</td><td class="NLM_def"><p class="first last">Knowledge Discovery Platform</p></td></tr><tr><td class="NLM_term">MCHR1</td><td class="NLM_def"><p class="first last">melanin-concentrating hormone receptor</p></td></tr><tr><td class="NLM_term">MCW</td><td class="NLM_def"><p class="first last">medicinal chemistry workflow</p></td></tr><tr><td class="NLM_term">MLNR</td><td class="NLM_def"><p class="first last">motilin receptor</p></td></tr><tr><td class="NLM_term">MOR</td><td class="NLM_def"><p class="first last">μ-opioid receptor</p></td></tr><tr><td class="NLM_term">MRC</td><td class="NLM_def"><p class="first last">Medical Research Council</p></td></tr><tr><td class="NLM_term">NIH</td><td class="NLM_def"><p class="first last">National Institutes of Health</p></td></tr><tr><td class="NLM_term">NK1</td><td class="NLM_def"><p class="first last">dual-acting neurokinin type 1</p></td></tr><tr><td class="NLM_term">P2X3</td><td class="NLM_def"><p class="first last">purinergic receptor P2X ligand-gated ion channel 3</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmacodynamic</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SOSA</td><td class="NLM_def"><p class="first last">selective optimization of side activities</p></td></tr><tr><td class="NLM_term">UnitTF-IDF</td><td class="NLM_def"><p class="first last">normalized term frequency–inverse document frequency vector</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Morgan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootendorst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lexchin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greyson, D.</span><span> </span><span class="NLM_article-title">The cost of drug development: a systematic review</span> <span class="citation_source-journal">Health Policy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fj.healthpol.2010.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=21256615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A280%3ADC%252BC3M3mtVentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4-17&author=S.+Morganauthor=P.+Grootendorstauthor=J.+Lexchinauthor=C.+Cunninghamauthor=D.+Greyson&title=The+cost+of+drug+development%3A+a+systematic+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The cost of drug development: a systematic review</span></div><div class="casAuthors">Morgan Steve; Grootendorst Paul; Lexchin Joel; Cunningham Colleen; Greyson Devon</div><div class="citationInfo"><span class="NLM_cas:title">Health policy (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  We aimed to systematically review and assess published estimates of the cost of developing new drugs.  METHODS:  We sought English language research articles containing original estimates of the cost of drug development that were published from 1980 to 2009, inclusive.  We searched seven databases and used citation tracing and expert referral to identify studies.  We abstracted qualifying studies for information about methods, data sources, study samples, and key results.  RESULTS:  Thirteen articles were found to meet our inclusion criteria.  Estimates of the cost of drug development ranged more than 9-fold, from USD$92 million cash (USD$161 million capitalized) to USD$883.6 million cash (USD$1.8 billion capitalized).  Differences in methods, data sources, and time periods explain some of the variation in estimates.  Lack of transparency limits many studies.  Confidential information provided by unnamed companies about unspecified products forms all or part of the data underlying 10 of the 13 studies.  CONCLUSIONS:  Despite three decades of research in this area, no published estimate of the cost of developing a drug can be considered a gold standard.  Studies on this topic should be subjected to reasonable audit and disclosure of - at the very least - the drugs which authors purport to provide development cost estimates for.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaRepHqeySwBfKb6ELK8t0fW6udTcc2ebpI1jD9dBrE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3mtVentQ%253D%253D&md5=9eed405260da92a72804838b2049dcb1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.healthpol.2010.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.healthpol.2010.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DS.%26aulast%3DGrootendorst%26aufirst%3DP.%26aulast%3DLexchin%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DC.%26aulast%3DGreyson%26aufirst%3DD.%26atitle%3DThe%2520cost%2520of%2520drug%2520development%253A%2520a%2520systematic%2520review%26jtitle%3DHealth%2520Policy%26date%3D2011%26volume%3D100%26spage%3D4%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Network pharmacology: the next paradigm in drug discovery</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1038%2Fnchembio.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=18936753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=682-690&author=A.+L.+Hopkins&title=Network+pharmacology%3A+the+next+paradigm+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology: the next paradigm in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">682-690</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The dominant paradigm in drug discovery is the concept of designing maximally selective ligands to act on individual drug targets.  However, many effective drugs act via modulation of multiple proteins rather than single targets.  Advances in systems biol. are revealing a phenotypic robustness and a network structure that strongly suggests that exquisitely selective compds., compared with multi-target drugs, may exhibit lower than desired clin. efficacy.  This new appreciation of the role of polypharmacol. has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity.  Integrating network biol. and polypharmacol. holds the promise of expanding the current opportunity space for druggable targets.  However, the rational design of polypharmacol. faces considerable challenges in the need for new methods to validate target combinations and optimize multiple structure-activity relationships while maintaining drug-like properties.  Advances in these areas are creating the foundation of the next paradigm in drug discovery: network pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqHy4FqkK-h7Vg90H21EOLACvtfcHk0lgNRTq-2BZ94A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK&md5=03b8be3ddbcab7dc65afd17df7ee8395</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.118%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DNetwork%2520pharmacology%253A%2520the%2520next%2520paradigm%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D682%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wishart, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassanali, M.</span><span> </span><span class="NLM_article-title">DrugBank: a knowledgebase for drugs, drug actions and drug targets</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">D901</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1093%2Fnar%2Fgkm958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=18048412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=D901-906&author=D.+S.+Wishartauthor=C.+Knoxauthor=A.+C.+Guoauthor=D.+Chengauthor=S.+Shrivastavaauthor=D.+Tzurauthor=B.+Gautamauthor=M.+Hassanali&title=DrugBank%3A+a+knowledgebase+for+drugs%2C+drug+actions+and+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank: a knowledgebase for drugs, drug actions and drug targets</span></div><div class="casAuthors">Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">Database Iss</span>),
    <span class="NLM_cas:pages">D901-D906</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank is a richly annotated resource that combines detailed drug data with comprehensive drug target and drug action information.  Since its first release in 2006, DrugBank has been widely used to facilitate in silico drug target discovery, drug design, drug docking or screening, drug metab. prediction, drug interaction prediction and general pharmaceutical education.  The latest version of DrugBank (release 2.0) has been expanded significantly over the previous release.  With ∼4900 drug entries, it now contains 60% more FDA-approved small mol. and biotech drugs including 10% more exptl.' drugs.  Significantly, more protein target data has also been added to the database, with the latest version of DrugBank contg. three times as many non-redundant protein or drug target sequences as before (1565 vs. 524).  Each DrugCard entry now contains more than 100 data fields with half of the information being devoted to drug/chem. data and the other half devoted to pharmacol., pharmacogenomic and mol. biol. data.  A no. of new data fields, including food-drug interactions, drug-drug interactions and exptl. ADME data have been added in response to numerous user requests.  DrugBank has also significantly improved the power and simplicity of its structure query and text query searches.  DrugBank is available at http://www.drugbank.ca.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqKjSWZe1ULVg90H21EOLACvtfcHk0lgNRTq-2BZ94A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSrs7Y%253D&md5=f8f8ca15f248b8c8b9c6d3bd0e85eec8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm958%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DShrivastava%26aufirst%3DS.%26aulast%3DTzur%26aufirst%3DD.%26aulast%3DGautam%26aufirst%3DB.%26aulast%3DHassanali%26aufirst%3DM.%26atitle%3DDrugBank%253A%2520a%2520knowledgebase%2520for%2520drugs%252C%2520drug%2520actions%2520and%2520drug%2520targets%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3DD901%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Yildırım, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusick, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabási, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, M.</span><span> </span><span class="NLM_article-title">Drug–target network</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1119-1126&author=M.+A.+Yild%C4%B1r%C4%B1mauthor=K.+I.+Gohauthor=M.+E.+Cusickauthor=A.+L.+Barab%C3%A1siauthor=M.+Vidal&title=Drug%E2%80%93target+network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYild%25C4%25B1r%25C4%25B1m%26aufirst%3DM.%2BA.%26aulast%3DGoh%26aufirst%3DK.%2BI.%26aulast%3DCusick%26aufirst%3DM.%2BE.%26aulast%3DBarab%25C3%25A1si%26aufirst%3DA.%2BL.%26aulast%3DVidal%26aufirst%3DM.%26atitle%3DDrug%25E2%2580%2593target%2520network%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1119%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mestres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregori-Puigjane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valverde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sole, R. V.</span><span> </span><span class="NLM_article-title">Data completeness—the Achilles heel of drug–target networks</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=983-984&author=J.+Mestresauthor=E.+Gregori-Puigjaneauthor=S.+Valverdeauthor=R.+V.+Sole&title=Data+completeness%E2%80%94the+Achilles+heel+of+drug%E2%80%93target+networks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMestres%26aufirst%3DJ.%26aulast%3DGregori-Puigjane%26aufirst%3DE.%26aulast%3DValverde%26aufirst%3DS.%26aulast%3DSole%26aufirst%3DR.%2BV.%26atitle%3DData%2520completeness%25E2%2580%2594the%2520Achilles%2520heel%2520of%2520drug%25E2%2580%2593target%2520networks%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D983%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Jalencas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestres, J.</span><span> </span><span class="NLM_article-title">On the origins of drug polypharmacology</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1039%2Fc2md20242e" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=80-87&author=X.+Jalencasauthor=J.+Mestres&title=On+the+origins+of+drug+polypharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2Fc2md20242e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20242e%26sid%3Dliteratum%253Aachs%26aulast%3DJalencas%26aufirst%3DX.%26aulast%3DMestres%26aufirst%3DJ.%26atitle%3DOn%2520the%2520origins%2520of%2520drug%2520polypharmacology%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D80%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Benson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pershadsingh, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittiboyina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pravenec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtz, T. W.</span><span> </span><span class="NLM_article-title">Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=993-1002&author=S.+C.+Bensonauthor=H.+A.+Pershadsinghauthor=C.+I.+Hoauthor=A.+Chittiboyinaauthor=P.+Desaiauthor=M.+Pravenecauthor=N.+Qiauthor=J.+Wangauthor=M.+A.+Averyauthor=T.+W.+Kurtz&title=Identification+of+telmisartan+as+a+unique+angiotensin+II+receptor+antagonist+with+selective+PPARgamma-modulating+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DS.%2BC.%26aulast%3DPershadsingh%26aufirst%3DH.%2BA.%26aulast%3DHo%26aufirst%3DC.%2BI.%26aulast%3DChittiboyina%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DP.%26aulast%3DPravenec%26aufirst%3DM.%26aulast%3DQi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAvery%26aufirst%3DM.%2BA.%26aulast%3DKurtz%26aufirst%3DT.%2BW.%26atitle%3DIdentification%2520of%2520telmisartan%2520as%2520a%2520unique%2520angiotensin%2520II%2520receptor%2520antagonist%2520with%2520selective%2520PPARgamma-modulating%2520activity%26jtitle%3DHypertension%26date%3D2004%26volume%3D43%26spage%3D993%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Benndorf, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwedhelm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, R. H.</span><span> </span><span class="NLM_article-title">Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension</span> <span class="citation_source-journal">Metabolism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1159</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fj.metabol.2006.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=16919533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlCisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=1159-1164&author=R.+A.+Benndorfauthor=T.+Rudolphauthor=D.+Appelauthor=E.+Schwedhelmauthor=R.+Maasauthor=F.+Schulzeauthor=E.+Silberhornauthor=R.+H.+Boger&title=Telmisartan+improves+insulin+sensitivity+in+nondiabetic+patients+with+essential+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension</span></div><div class="casAuthors">Benndorf, Ralf A.; Rudolph, Tanja; Appel, Daniel; Schwedhelm, Edzard; Maas, Renke; Schulze, Friedrich; Silberhorn, Elisabeth; Boeger, Rainer H.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1159-1164</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hypertension is a cardiovascular risk factor commonly assocd. with insulin resistance, the metabolic syndrome, and type 2 diabetes mellitus.  Recent in vitro data indicate that certain angiotensin receptor antagonists, for example, telmisartan, activate peroxisome proliferator-activated receptor γ (PPAR-γ) and increase adiponectin protein content in adipocytes.  By this means, they may improve insulin sensitivity in vivo.  To investigate the effect of antihypertensive treatment on insulin sensitivity and fasting adiponectin serum levels, 37 nondiabetic patients with essential hypertension were randomized to receive telmisartan, the calcium channel blocker nisoldipine, or their combination for 6 wk in a prospective, parallel group study.  Fasting serum glucose, insulin, and adiponectin were evaluated before, 3 wk (low dose), and 6 wk (high dose) after initiation of treatment.  Furthermore, the effect of telmisartan on PPAR-γ receptor activity was investigated in vitro using a PPAR-γ reporter gene assay.  As reported previously, telmisartan significantly enhanced PPAR-γ receptor activity in vitro.  At baseline, a pos. correlation between insulin serum levels and body mass index of investigated subjects was obsd., whereas body mass index and serum adiponectin levels were neg. assocd.  High-dose treatment with telmisartan but not with nisoldipine reduced serum insulin levels as well as the homeostasis model assessment of insulin resistance, but did not affect serum adiponectin levels.  In conclusion, in our study cohort of nondiabetic patients with essential hypertension, telmisartan improved insulin sensitivity by mechanisms apparently not involving adiponectin induction.  Future studies will demonstrate whether these telmisartan-induced effects may contribute to a blood pressure-independent redn. in cardiovascular morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLs94y4mjpcbVg90H21EOLACvtfcHk0lhQ15WztmpDuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlCisbk%253D&md5=dec4065c7925b138fa2721638b48cf41</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2006.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2006.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DBenndorf%26aufirst%3DR.%2BA.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DAppel%26aufirst%3DD.%26aulast%3DSchwedhelm%26aufirst%3DE.%26aulast%3DMaas%26aufirst%3DR.%26aulast%3DSchulze%26aufirst%3DF.%26aulast%3DSilberhorn%26aufirst%3DE.%26aulast%3DBoger%26aufirst%3DR.%2BH.%26atitle%3DTelmisartan%2520improves%2520insulin%2520sensitivity%2520in%2520nondiabetic%2520patients%2520with%2520essential%2520hypertension%26jtitle%3DMetabolism%26date%3D2006%26volume%3D55%26spage%3D1159%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Peters, J. U.</span>, Ed.  <span class="citation_source-book">Polypharmacology in Drug Discovery</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1002%2F9781118098141" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+U.+Peters&title=Polypharmacology+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F9781118098141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118098141%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26btitle%3DPolypharmacology%2520in%2520Drug%2520Discovery%26pub%3DWiley%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Morphy, J. R.; Harris, C. J.</span> <span class="citation_source-book">Designing Multi-Target Drugs</span>; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1039%2F9781849734912" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+R.+Morphy&author=C.+J.+Harris&title=Designing+Multi-Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2F9781849734912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849734912%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26btitle%3DDesigning%2520Multi-Target%2520Drugs%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">The use of multi-target drugs in the treatment of neurodegenerative diseases</span> <span class="citation_source-journal">Expert Rev. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1586%2Fecp.11.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFGgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=293-298&author=C.+J.+Van+der+Schyf&title=The+use+of+multi-target+drugs+in+the+treatment+of+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The use of multi-target drugs in the treatment of neurodegenerative diseases</span></div><div class="casAuthors">Van der Schyf, Cornelis J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-298</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders lead to increased mortality and morbidity in older patients, and are a great burden on society, where there is currently no approved treatment to prevent the progression of these diseases.  Many clinicians and basic scientists have become persuaded that a strategy aimed at the simultaneous targeting of multiple proteins (and therefore etiologies) involved in the development of a disease should be more beneficial than the currently accepted 'silver bullet' approach.  Select examples of multi-target drug candidates currently under investigation for neurodegenerative diseases are shown.  Importantly, such transition from a 'magic bullet' to a 'magic shotgun' approach may be key in designing future treatment regimens for neurodegenerative diseases and assocd. cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAwTj0XbQk3LVg90H21EOLACvtfcHk0lhQ15WztmpDuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFGgsrk%253D&md5=7aa001180af3e144548f7f617aa12c2d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1586%2Fecp.11.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fecp.11.13%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520use%2520of%2520multi-target%2520drugs%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D4%26spage%3D293%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designing multiple ligands—medicinal chemistry strategies and challenges</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.2174%2F138161209787315594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=19199984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=587-600&author=R.+Morphyauthor=Z.+Rankovic&title=Designing+multiple+ligands%E2%80%94medicinal+chemistry+strategies+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Designing multiple ligands - medicinal chemistry strategies and challenges</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">587-600</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been widely recognized over the recent years that parallel modulation of multiple biol. targets can be beneficial for treatment of diseases with complex etiologies such as cancer asthma, and psychiatric disease.  In this article, current strategies for the generation of ligands with a specific multi-target profile (designed multiple ligands or DMLs) are described and a no. of illustrative example are given.  Designing multiple ligands is frequently a challenging endeavor for medicinal chemists, with the need to appropriately balance affinity for 2 or more targets while obtaining physicochem. and pharmacokinetic properties that are consistent with the administration of an oral drug.  Given that the properties of DMLs are influenced to a large extent by the proteomic superfamily to which the targets belong and the lead generation strategy that is pursued, an early assessment of the feasibility of any given DML project is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUo6NjoK5D-LVg90H21EOLACvtfcHk0lhi3XcwgAS5Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D&md5=fa34039be6e9c3b489f530fc74fd0346</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138161209787315594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315594%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigning%2520multiple%2520ligands%25E2%2580%2594medicinal%2520chemistry%2520strategies%2520and%2520challenges%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D587%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Designed multiple ligands: basic research vs clinical outcomes</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3353</span><span class="NLM_x">–</span> <span class="NLM_lpage">3387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.2174%2F092986712801215883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=22680630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOhtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3353-3387&author=L.+Costantinoauthor=D.+Barlocco&title=Designed+multiple+ligands%3A+basic+research+vs+clinical+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Designed multiple ligands: basic research vs clinical outcomes</span></div><div class="casAuthors">Costantino, L.; Barlocco, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3353-3387</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The clin. treatment of multifactorial pathologies (e.g. cancer, Alzheimer's disease, psychiatric disorders), is still a major challenge.  Many researches have been published dealing with the design of multiple ligands, able to act at the same time towards several targets relevant for a given pathol.  In the present review, the clin. results about these compds. have been reported, together with the design strategy adopted, in order to allow a crit. evaluation of the outcomes of these efforts.  What is emerging is that several effective design strategies of multitarget compds. are available, and the choice among these appears to be dependent on the therapeutic area considered.  However, at present, besides multitarget drugs discovered during optimization efforts by means of phenotypic assays, drug coadministrations or fixed dose formulations appear to be more useful therapeutic options than designed multiple ligands; this scenario will change when systems biol. will be able to select crit. targets, i.e. nodal proteins that should be inhibited in order to obtain a therapeutic action; at this point, the design of multiple ligands will allow a renaissance of medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobv_P2UM6L_7Vg90H21EOLACvtfcHk0lhi3XcwgAS5Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOhtrrN&md5=82123bbafc10a19c65a0bc0c5be72546</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F092986712801215883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712801215883%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DDesigned%2520multiple%2520ligands%253A%2520basic%2520research%2520vs%2520clinical%2520outcomes%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3353%26epage%3D3387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzek, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karapetyan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dracheva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gindulyte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, S. H.</span><span> </span><span class="NLM_article-title">PubChem’s BioAssay Database</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D400</span><span class="NLM_x">–</span> <span class="NLM_lpage">D412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D400-D412&author=Y.+Wangauthor=J.+Xiaoauthor=T.+O.+Suzekauthor=J.+Zhangauthor=J.+Wangauthor=Z.+Zhouauthor=L.+Hanauthor=K.+Karapetyanauthor=S.+Drachevaauthor=B.+A.+Shoemakerauthor=E.+Boltonauthor=A.+Gindulyteauthor=S.+H.+Bryant&title=PubChem%E2%80%99s+BioAssay+Database"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DSuzek%26aufirst%3DT.%2BO.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DKarapetyan%26aufirst%3DK.%26aulast%3DDracheva%26aufirst%3DS.%26aulast%3DShoemaker%26aufirst%3DB.%2BA.%26aulast%3DBolton%26aufirst%3DE.%26aulast%3DGindulyte%26aufirst%3DA.%26aulast%3DBryant%26aufirst%3DS.%2BH.%26atitle%3DPubChem%25E2%2580%2599s%2520BioAssay%2520Database%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD400%26epage%3DD412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Gaulton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellis, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalovich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">ChEMBL: a large-scale bioactivity database for drug discovery</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1093%2Fnar%2Fgkr777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=21948594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D1100-D1107&author=A.+Gaultonauthor=L.+J.+Bellisauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Herseyauthor=Y.+Lightauthor=S.+McGlincheyauthor=D.+Michalovichauthor=B.+Al-Lazikaniauthor=J.+P.+Overington&title=ChEMBL%3A+a+large-scale+bioactivity+database+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL: a large-scale bioactivity database for drug discovery</span></div><div class="casAuthors">Gaulton, Anna; Bellis, Louisa J.; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Hersey, Anne; Light, Yvonne; McGlinchey, Shaun; Michalovich, David; Al-Lazikani, Bissan; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1100-D1107</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an Open Data database contg. binding, functional and ADMET information for a large no. of drug-like bioactive compds.  These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chem. biol. and drug-discovery research problems.  Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compds. and 5200 protein targets.  Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9e9jRENTtubVg90H21EOLACvtfcHk0lj5bl2Ly3HCyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN&md5=aedf7793e1ca54b6a4fa272ea3ef7d0e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr777%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DMichalovich%26aufirst%3DD.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DChEMBL%253A%2520a%2520large-scale%2520bioactivity%2520database%2520for%2520drug%2520discovery%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD1100%26epage%3DD1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Krejsa, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogalski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penzotti, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migeon, J. C.</span><span> </span><span class="NLM_article-title">Predicting ADME properties and side effects: the BioPrint approach</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=12951810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=470-480&author=C.+M.+Krejsaauthor=D.+Horvathauthor=S.+L.+Rogalskiauthor=J.+E.+Penzottiauthor=B.+Maoauthor=F.+Barbosaauthor=J.+C.+Migeon&title=Predicting+ADME+properties+and+side+effects%3A+the+BioPrint+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting ADME properties and side effects: The BioPrint approach</span></div><div class="casAuthors">Krejsa, Cecile M.; Horvath, Dragos; Rogalski, Sherri L.; Penzotti, Julie E.; Mao, Boryeu; Barbosa, Frederique; Migeon, Jacques C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">470-480</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Current Drugs</span>)
        </div><div class="casAbstract">A review.  Computational methods are increasingly used to streamline and enhance the lead discovery and optimization process.  However, accurate prediction of absorption, distribution, metab. and excretion (ADME) and adverse drug reactions (ADR) is often difficult, due to the complexity of underlying physiol. mechanisms.  Modeling approaches have been hampered by the lack of large, robust and standardized training datasets.  In an extensive effort to build such a dataset, the BioPrint database was constructed by systematic profiling of nearly all drugs available on the market, as well as numerous ref. compds.  The database is composed of several large datasets: compd. structures and mol. descriptors, in vitro ADME and pharmacol. profiles, and complementary clin. data including therapeutic use information, pharmacokinetics profiles and ADR profiles.  These data have allowed the development of computational tools designed to integrate a program of computational chem. into library design and lead development.  Models based on chem. structure are strengthened by in vitro results that can be used as addnl. compd. descriptors to predict complex in vivo endpoints.  The BioPrint pharmacoinformatics platform represents a systematic effort to accelerate the process of drug discovery, improve quant. structure-activity relationships and develop in vitro/in vivo assocns.  In this review, we will discuss the importance of training set size and diversity in model development, the implementation of linear and neighborhood modeling approaches, and the use of in silico methods to predict potential clin. liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQ71juUoErrVg90H21EOLACvtfcHk0lj5bl2Ly3HCyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFymsLw%253D&md5=f8db4e37cc895d67bf4a82efe021c5c2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrejsa%26aufirst%3DC.%2BM.%26aulast%3DHorvath%26aufirst%3DD.%26aulast%3DRogalski%26aufirst%3DS.%2BL.%26aulast%3DPenzotti%26aufirst%3DJ.%2BE.%26aulast%3DMao%26aufirst%3DB.%26aulast%3DBarbosa%26aufirst%3DF.%26aulast%3DMigeon%26aufirst%3DJ.%2BC.%26atitle%3DPredicting%2520ADME%2520properties%2520and%2520side%2520effects%253A%2520the%2520BioPrint%2520approach%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2003%26volume%3D6%26spage%3D470%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span> <span class="citation_source-book">GOSTAR (GVK BIO Online Structure Activity Relationship Database)</span>; <span class="NLM_publisher-name">GVK Biosciences Private Limited, S-1, Phase-1, T.I.E.</span>: <span class="NLM_publisher-loc">Hyderabad, A.P, India</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GOSTAR+%28GVK+BIO+Online+Structure+Activity+Relationship+Database%29%3B+GVK+Biosciences+Private+Limited%2C+S-1%2C+Phase-1%2C+T.I.E.%3A+Hyderabad%2C+A.P%2C+India%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGOSTAR%2520%2528GVK%2520BIO%2520Online%2520Structure%2520Activity%2520Relationship%2520Database%2529%26pub%3DGVK%2520Biosciences%2520Private%2520Limited%252C%2520S-1%252C%2520Phase-1%252C%2520T.I.E%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Fliri, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loging, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R. A.</span><span> </span><span class="NLM_article-title">Drug effects viewed from a signal transduction network perspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8038</span><span class="NLM_x">–</span> <span class="NLM_lpage">8046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901001p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=8038-8046&author=A.+F.+Fliriauthor=W.+T.+Logingauthor=R.+A.+Volkmann&title=Drug+effects+viewed+from+a+signal+transduction+network+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901001p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901001p%26sid%3Dliteratum%253Aachs%26aulast%3DFliri%26aufirst%3DA.%2BF.%26aulast%3DLoging%26aufirst%3DW.%2BT.%26aulast%3DVolkmann%26aufirst%3DR.%2BA.%26atitle%3DDrug%2520effects%2520viewed%2520from%2520a%2520signal%2520transduction%2520network%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D8038%26epage%3D8046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Paolini, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapland, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoorn, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Global mapping of pharmacological space</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1038%2Fnbt1228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=16841068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=805-815&author=G.+V.+Paoliniauthor=R.+H.+Shaplandauthor=W.+P.+van+Hoornauthor=J.+S.+Masonauthor=A.+L.+Hopkins&title=Global+mapping+of+pharmacological+space"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Global mapping of pharmacological space</span></div><div class="casAuthors">Paolini, Gaia V.; Shapland, Richard H. B.; van Hoorn, Willem P.; Mason, Jonathan S.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We present the global mapping of pharmacol. space by the integration of several vast sources of medicinal chem. structure-activity relationships (SAR) data.  Our comprehensive mapping of pharmacol. space enables us to identify confidently the human targets for which chem. tools and drugs have been discovered to date.  The integration of SAR data from diverse sources by unique canonical chem. structure, protein sequence and disease indication enables the construction of a ligand-target matrix to explore the global relationships between chem. structure and biol. targets.  Using the data matrix, we are able to catalog the links between proteins in chem. space as a polypharmacol. interaction network.  We demonstrate that probabilistic models can be used to predict pharmacol. from a large knowledge base.  The relationships between proteins, chem. structures and drug-like properties provide a framework for developing a probabilistic approach to drug discovery that can be exploited to increase research productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV_CE47zZq8LVg90H21EOLACvtfcHk0liQCoJOdSzYSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFansb8%253D&md5=f559b34692cc903a1b503deb07030c5d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnbt1228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1228%26sid%3Dliteratum%253Aachs%26aulast%3DPaolini%26aufirst%3DG.%2BV.%26aulast%3DShapland%26aufirst%3DR.%2BH.%26aulast%3Dvan%2BHoorn%26aufirst%3DW.%2BP.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DGlobal%2520mapping%2520of%2520pharmacological%2520space%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D805%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Boran, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, R.</span><span> </span><span class="NLM_article-title">Systems approaches to polypharmacology and drug discovery</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=20443163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFCqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=297-309&author=A.+D.+Boranauthor=R.+Iyengar&title=Systems+approaches+to+polypharmacology+and+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Systems approaches to polypharmacology and drug discovery</span></div><div class="casAuthors">Boran, Aislyn D. W.; Iyengar, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-309</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Systems biol. uses exptl. and computational approaches to characterize large sample populations systematically, process large datasets, examine and analyze regulatory networks, and model reactions to det. how components are joined to form functional systems.  Systems biol. technologies, data and knowledge are particularly useful in understanding disease processes and drug actions.  An important area of integration between systems biol. and drug discovery is the concept of polypharmacol.: the treatment of diseases by modulating more than one target.  Polypharmacol. for complex diseases is likely to involve multiple drugs acting on distinct targets that are part of a network regulating physiol. responses.  This review discusses the current state of the systems-level understanding of diseases and both the therapeutic and adverse mechanisms of drug actions.  Drug-target networks can be used to identify multiple targets and to det. suitable combinations of drug targets or drugs.  Thus, the discovery of new drug therapies for complex diseases may be greatly aided by systems biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7lrjWtBIXI7Vg90H21EOLACvtfcHk0ljewpC_bVlOiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFCqtrk%253D&md5=b26a44ecd76a605816e08985ff8a576f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoran%26aufirst%3DA.%2BD.%26aulast%3DIyengar%26aufirst%3DR.%26atitle%3DSystems%2520approaches%2520to%2520polypharmacology%2520and%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D297%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Maglott, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruitt, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatusova, T.</span><span> </span><span class="NLM_article-title">Entrez Gene: gene-centered information at NCBI</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D52</span><span class="NLM_x">–</span> <span class="NLM_lpage">D57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D52-D57&author=D.+Maglottauthor=J.+Ostellauthor=K.+D.+Pruittauthor=T.+Tatusova&title=Entrez+Gene%3A+gene-centered+information+at+NCBI"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaglott%26aufirst%3DD.%26aulast%3DOstell%26aufirst%3DJ.%26aulast%3DPruitt%26aufirst%3DK.%2BD.%26aulast%3DTatusova%26aufirst%3DT.%26atitle%3DEntrez%2520Gene%253A%2520gene-centered%2520information%2520at%2520NCBI%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD52%26epage%3DD57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljewpC_bVlOiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0liuU0RnhUQadw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Patchett, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, R. P.</span><span> </span><span class="NLM_article-title">Privileged structures—an update</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=289-298&author=A.+A.+Patchettauthor=R.+P.+Nargund&title=Privileged+structures%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26atitle%3DPrivileged%2520structures%25E2%2580%2594an%2520update%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2000%26volume%3D35%26spage%3D289%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gloriam, D. E.</span><span> </span><span class="NLM_article-title">Chemogenomics of allosteric binding sites in GPCRs</span>.  <span class="citation_source-journal">Drug Discovery Today: Technol.</span> [Online eary access]. DOI: <span class="refDoi"> DOI: 10.1016/i.ddtec.2012.07.010</span> . Published Online:<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fi.ddtec.2012.07.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+E.+Gloriam&title=Chemogenomics+of+allosteric+binding+sites+in+GPCRs&doi=10.1016%2Fi.ddtec.2012.07.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fi.ddtec.2012.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fi.ddtec.2012.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DChemogenomics%2520of%2520allosteric%2520binding%2520sites%2520in%2520GPCRs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26doi%3D10.1016%2Fi.ddtec.2012.07.010%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Pang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. H.</span><span> </span><span class="NLM_article-title">A series of case studies: practical methodology for identifying antinociceptive multi-target drugs</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fj.drudis.2012.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=22269134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslymsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=425-434&author=M.+H.+Pangauthor=Y.+Kimauthor=K.+W.+Jungauthor=S.+Choauthor=D.+H.+Lee&title=A+series+of+case+studies%3A+practical+methodology+for+identifying+antinociceptive+multi-target+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A series of case studies: practical methodology for identifying antinociceptive multi-target drugs</span></div><div class="casAuthors">Pang, Min-Hee; Kim, Yuntae; Jung, Kyung Woon; Cho, Sunyoung; Lee, Doo H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">425-434</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the introduction of drug discovery based on single targets, the no. of newly developed drugs has steadily declined, and the reliability of the current drug-discovery paradigm has been unceasingly questioned.  As an alternative, an emerging approach pursuing multi-targeting drugs has arisen to reflect multifactorial diseases caused by the complex networks of various mechanisms.  The purpose of this paper is to review multi-target drugs and introduce our progress in establishing a practical methodol. for identifying antinociceptive multi-target drugs.  We have adopted a system of ex vivo efficacy screening using long-term potentiation in rat spinal cord as a surrogate biomarker for neuropathic pain.  A bait-target approach is also adopted to lure an unknown target combination that induces synergistic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooIysgrC1A57Vg90H21EOLACvtfcHk0liuU0RnhUQadw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslymsb8%253D&md5=e049704990e8d69b5a91e2b11824fe7f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DJung%26aufirst%3DK.%2BW.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DD.%2BH.%26atitle%3DA%2520series%2520of%2520case%2520studies%253A%2520practical%2520methodology%2520for%2520identifying%2520antinociceptive%2520multi-target%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D425%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bureeva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvereva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryiskaya, T.</span><span> </span><span class="NLM_article-title">Manual annotation of protein interactions</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">563</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1007%2F978-1-60761-175-2_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=19597781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVKhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2009&pages=75-95&author=S.+Bureevaauthor=S.+Zverevaauthor=V.+Romanovauthor=T.+Serebryiskaya&title=Manual+annotation+of+protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Manual annotation of protein interactions</span></div><div class="casAuthors">Bureeva, Svetlana; Zvereva, Svetlana; Romanov, Valentin; Serebryiskaya, Tatiana</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">Protein Networks and Pathway Analysis</span>),
    <span class="NLM_cas:pages">75-95</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Protein interactions are the basic building blocks for assembly of pathways and networks.  Almost any biol. meaningful functionality (for instance, linear signaling pathways, chains of metabolic reactions, transcription factor dimmers, protein complexes of transcriptosome, gene-disease assocns.) can be represented as a combination of binary relationships between "network objects" (genes, proteins, RNA species, bioactive compds.).  Naturally, the assembled pathways and networks are only as good as their "weakest" link (i.e., a wrongly assigned interaction), and the errors multiply in multi-step pathways.  Therefore, the utility of "systems biol." is fundamentally dependent on quality and relevance of protein interactions.  The second important parameter is the sheer no. of interactions assembled in the database.  One needs a "crit. mass" of species-specific interactions in order to build cohesive networks for a gene list, not a constellation of non-connected proteins and protein pairs.  The third issue is semantic consistency between interactions of different types.  Transient phys. signal transduction interactions, reactions of endogenous metab., transcription factor-promoter binding, and kinetic drug-target interactions are all very different in nature.  Yet, they have to fit well into one database format and be consistent in order to be useful in reconstruction of cellular processes.  High-quality protein interactions are available in peer-reviewed "small expt." literature and, to a much smaller extent, patents.  However, it is very challenging to find the interactions, annotate with searchable (and computable) parameters, catalog in the database format in computer readable form, and assemble into a database.  There are hundreds of thousands of mammalian interactions scattered in tens of thousands of papers in a few thousands of scientific journals.  There are no widely used stds. for reporting the interactions in scientific texts and, therefore, text-mining tools have only limited applicability.  In order to generate a meaningful database of protein interactions, one needs a well-developed technol. of manual curation, equipped with computational solns., managerial procedures, quality control, and users' feedback.  Here we describe our ever-evolving annotation approach, the important annotation issues and our solns., and the mammalian protein interactions database MetaBase which we have been working on for over 8 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooFH7AtAKh17Vg90H21EOLACvtfcHk0ljmiFBArasGDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVKhu7w%253D&md5=c01400c84882d0e5ab98d6180868108d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2F978-1-60761-175-2_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60761-175-2_5%26sid%3Dliteratum%253Aachs%26aulast%3DBureeva%26aufirst%3DS.%26aulast%3DZvereva%26aufirst%3DS.%26aulast%3DRomanov%26aufirst%3DV.%26aulast%3DSerebryiskaya%26aufirst%3DT.%26atitle%3DManual%2520annotation%2520of%2520protein%2520interactions%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2009%26volume%3D563%26spage%3D75%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Inui, A.</span><span> </span><span class="NLM_article-title">Ghrelin: an orexigenic and somatotrophic signal from the stomach</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1038%2F35086018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=11483998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtVaqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=551-560&author=A.+Inui&title=Ghrelin%3A+an+orexigenic+and+somatotrophic+signal+from+the+stomach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin: An orexigenic and somatotrophic signal from the stomach</span></div><div class="casAuthors">Inui, Akio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">551-560</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 142 refs.  Ghrelin, an endogenous ligand for the growth hormone secretagogue receptor, is synthesized principally in the stomach and is released in response to fasting.  Ghrelin is structurally related to motilin and, together, they represent a novel family of gut-brain regulatory peptides.  In addn. to having a powerful effect on the secretion of growth hormone, ghrelin stimulates energy prodn. and signals directly to the hypothalamic regulatory nuclei that control energy homeostasis.  The study of ghrelin has extended the understanding of how growth is controlled, and has shown that the stomach is an important component of this system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBjETEEWi65bVg90H21EOLACvtfcHk0ljmiFBArasGDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtVaqtbo%253D&md5=ece77aa575192edd1ad0044cfd55b803</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2F35086018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35086018%26sid%3Dliteratum%253Aachs%26aulast%3DInui%26aufirst%3DA.%26atitle%3DGhrelin%253A%2520an%2520orexigenic%2520and%2520somatotrophic%2520signal%2520from%2520the%2520stomach%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D2%26spage%3D551%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochiki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwano, H.</span><span> </span><span class="NLM_article-title">The roles of motilin and ghrelin in gastrointestinal motility</span> <span class="citation_source-journal">Int. J. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">820794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=820794&author=T.+Ohnoauthor=E.+Mochikiauthor=H.+Kuwano&title=The+roles+of+motilin+and+ghrelin+in+gastrointestinal+motility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DT.%26aulast%3DMochiki%26aufirst%3DE.%26aulast%3DKuwano%26aufirst%3DH.%26atitle%3DThe%2520roles%2520of%2520motilin%2520and%2520ghrelin%2520in%2520gastrointestinal%2520motility%26jtitle%3DInt.%2520J.%2520Pept.%26date%3D2010%26volume%3D2010%26spage%3D820794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Bailey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basilla, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleury, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlek, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westaway, S. M.</span><span> </span><span class="NLM_article-title">The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6452</span><span class="NLM_x">–</span> <span class="NLM_lpage">6458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6452-6458&author=J.+M.+Baileyauthor=J.+S.+Scottauthor=J.+B.+Basillaauthor=V.+J.+Boltonauthor=I.+Boyfieldauthor=D.+G.+Evansauthor=E.+Fleuryauthor=T.+D.+Heightmanauthor=E.+M.+Jarvieauthor=K.+Lawlessauthor=K.+L.+Matthewsauthor=F.+McKayauthor=H.+Mokauthor=A.+Muirauthor=B.+S.+Orlekauthor=G.+J.+Sangerauthor=G.+Stempauthor=A.+J.+Stevensauthor=M.+Thompsonauthor=J.+Wardauthor=K.+Vaidyaauthor=S.+M.+Westaway&title=The+discovery+and+optimisation+of+benzazepine+sulfonamide+and+sulfones+as+potent+agonists+of+the+motilin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DBasilla%26aufirst%3DJ.%2BB.%26aulast%3DBolton%26aufirst%3DV.%2BJ.%26aulast%3DBoyfield%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DD.%2BG.%26aulast%3DFleury%26aufirst%3DE.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DJarvie%26aufirst%3DE.%2BM.%26aulast%3DLawless%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DK.%2BL.%26aulast%3DMcKay%26aufirst%3DF.%26aulast%3DMok%26aufirst%3DH.%26aulast%3DMuir%26aufirst%3DA.%26aulast%3DOrlek%26aufirst%3DB.%2BS.%26aulast%3DSanger%26aufirst%3DG.%2BJ.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DVaidya%26aufirst%3DK.%26aulast%3DWestaway%26aufirst%3DS.%2BM.%26atitle%3DThe%2520discovery%2520and%2520optimisation%2520of%2520benzazepine%2520sulfonamide%2520and%2520sulfones%2520as%2520potent%2520agonists%2520of%2520the%2520motilin%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6452%26epage%3D6458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Holzer, P.</span><span> </span><span class="NLM_article-title">Opioid receptors in the gastrointestinal tract</span> <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fj.regpep.2009.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=19345246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1aju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2009&pages=11-17&author=P.+Holzer&title=Opioid+receptors+in+the+gastrointestinal+tract"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid receptors in the gastrointestinal tract</span></div><div class="casAuthors">Holzer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Opium is arguably one of the oldest herbal medicines, being used as analgesic, sedative and antidiarrheal drug for thousands of years.  These effects mirror the actions of the endogenous opioid system and are mediated by the principal μ-, κ- and δ-opioid receptors.  In the gut, met-enkephalin, leu-enkephalin, β-endorphin and dynorphin occur in both neurons and endocrine cells.  When released, opioid peptides activate opioid receptors on the enteric circuitry controlling motility and secretion.  As a result, inhibition of gastric emptying, increase in sphincter tone, induction of stationary motor patterns and blockade of peristalsis ensue.  Together with inhibition of ion and fluid secretion, these effects cause constipation, one of the most frequent and troublesome adverse reactions of opioid analgesic therapy.  Although laxatives are most frequently used to ameliorate opioid-induced bowel dysfunction, their efficacy is unsatisfactory.  Specific antagonism of peripheral opioid receptors is a more rational approach.  This goal is addressed by the use of opioid receptor antagonists with limited absorption such as oral prolonged-release naloxone and opioid receptor antagonists that do not penetrate the blood-brain barrier such as methylnaltrexone and alvimopan.  Preliminary evidence indicates that peripherally restricted opioid receptor antagonists may act as prokinetic drugs in their own right.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGott_ZsCD5bm7Vg90H21EOLACvtfcHk0liMD5rB3_Esnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1aju7w%253D&md5=0add06dd2fd0767672c99daaf078d74b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.regpep.2009.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.regpep.2009.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DHolzer%26aufirst%3DP.%26atitle%3DOpioid%2520receptors%2520in%2520the%2520gastrointestinal%2520tract%26jtitle%3DRegul.%2520Pept.%26date%3D2009%26volume%3D155%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Shimizu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takewaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furness, J. B.</span><span> </span><span class="NLM_article-title">Tachykinins and their functions in the gastrointestinal tract</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1007%2Fs00018-007-7148-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=17952369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Cqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=295-311&author=Y.+Shimizuauthor=H.+Matsuyamaauthor=T.+Shiinaauthor=T.+Takewakiauthor=J.+B.+Furness&title=Tachykinins+and+their+functions+in+the+gastrointestinal+tract"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tachykinins and their functions in the gastrointestinal tract</span></div><div class="casAuthors">Shimizu, Y.; Matsuyama, H.; Shiina, T.; Takewaki, T.; Furness, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-311</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  In the gastrointestinal tract, tachykinins are peptide neurotransmitters in nerve circuits that regulate intestinal motility, secretion, and vascular functions.  Tachykinins also contribute to transmission from spinal afferents that innervate the gastrointestinal tract and have roles in the responses of the intestine to inflammation.  Tachykinins coexist with acetylcholine, the primary transmitter of excitatory neurons innervating the muscle, and act as a co-neurotransmitter of excitatory neurons.  Excitatory transmission is mediated through NK1 receptors (primarily on interstitial cells of Cajal) and NK2 receptors on the muscle.  Tachykinins participate in slow excitatory transmission at neuro-neuronal synapses, through NK1 and NK3 receptors, in both ascending and descending pathways affecting motility.  Activation of receptors (NK1 and NK2) on the epithelium causes fluid secretion.  Tachykinin receptors on immune cells are activated during inflammation of the gut.  Finally, tachykinins are released from the central terminals of gastrointestinal afferent neurons in the spinal cord, particularly in nociceptive pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreZGFy-NYRKbVg90H21EOLACvtfcHk0liMD5rB3_Esnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Cqsbo%253D&md5=2965d955343372e4c49c93e53cab5a68</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7148-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7148-1%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DMatsuyama%26aufirst%3DH.%26aulast%3DShiina%26aufirst%3DT.%26aulast%3DTakewaki%26aufirst%3DT.%26aulast%3DFurness%26aufirst%3DJ.%2BB.%26atitle%3DTachykinins%2520and%2520their%2520functions%2520in%2520the%2520gastrointestinal%2520tract%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D295%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Walsh, S.; Heilig, M.; Nuzzo, A. P.; Henderson, P.; Lofwall, R. M.</span><span> </span><span class="NLM_article-title">Effects of the NK(1) antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers</span>.  <span class="citation_source-journal">Addict. Biol.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1111/j.1369-1600.2011.00419.x</span> . Published Online: Jan 19,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1111%2Fj.1369-1600.2011.00419.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+Walsh&author=M.+Heilig&author=A.+P.+Nuzzo&author=P.+Henderson&author=R.+M.+Lofwall&title=Effects+of+the+NK%281%29+antagonist%2C+aprepitant%2C+on+response+to+oral+and+intranasal+oxycodone+in+prescription+opioid+abusers&doi=10.1111%2Fj.1369-1600.2011.00419.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2011.00419.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2011.00419.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DS.%26atitle%3DEffects%2520of%2520the%2520NK%25281%2529%2520antagonist%252C%2520aprepitant%252C%2520on%2520response%2520to%2520oral%2520and%2520intranasal%2520oxycodone%2520in%2520prescription%2520opioid%2520abusers%26jtitle%3DAddict.%2520Biol.%26doi%3D10.1111%2Fj.1369-1600.2011.00419.x%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Vardanyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumirov, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichol, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liktor-Busa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6135</span><span class="NLM_x">–</span> <span class="NLM_lpage">6142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6135-6142&author=R.+Vardanyanauthor=V.+K.+Kumirovauthor=G.+S.+Nicholauthor=P.+Davisauthor=E.+Liktor-Busaauthor=D.+Rankinauthor=E.+Vargaauthor=T.+Vanderahauthor=F.+Porrecaauthor=J.+Laiauthor=V.+J.+Hruby&title=Synthesis+and+biological+evaluation+of+new+opioid+agonist+and+neurokinin-1+antagonist+bivalent+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVardanyan%26aufirst%3DR.%26aulast%3DKumirov%26aufirst%3DV.%2BK.%26aulast%3DNichol%26aufirst%3DG.%2BS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DLiktor-Busa%26aufirst%3DE.%26aulast%3DRankin%26aufirst%3DD.%26aulast%3DVarga%26aufirst%3DE.%26aulast%3DVanderah%26aufirst%3DT.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520opioid%2520agonist%2520and%2520neurokinin-1%2520antagonist%2520bivalent%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6135%26epage%3D6142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ballet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feytens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buysse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keresztes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Duppen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanden Broeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourwe, D.</span><span> </span><span class="NLM_article-title">Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2476</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1016285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2467-2476&author=S.+Balletauthor=D.+Feytensauthor=K.+Buysseauthor=N.+N.+Chungauthor=C.+Lemieuxauthor=S.+Tumatiauthor=A.+Keresztesauthor=J.+Van+Duppenauthor=J.+Laiauthor=E.+Vargaauthor=F.+Porrecaauthor=P.+W.+Schillerauthor=J.+Vanden+Broeckauthor=D.+Tourwe&title=Design+of+novel+neurokinin+1+receptor+antagonists+based+on+conformationally+constrained+aromatic+amino+acids+and+discovery+of+a+potent+chimeric+opioid+agonist-neurokinin+1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm1016285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1016285%26sid%3Dliteratum%253Aachs%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DFeytens%26aufirst%3DD.%26aulast%3DBuysse%26aufirst%3DK.%26aulast%3DChung%26aufirst%3DN.%2BN.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DTumati%26aufirst%3DS.%26aulast%3DKeresztes%26aufirst%3DA.%26aulast%3DVan%2BDuppen%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DVarga%26aufirst%3DE.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DVanden%2BBroeck%26aufirst%3DJ.%26aulast%3DTourwe%26aufirst%3DD.%26atitle%3DDesign%2520of%2520novel%2520neurokinin%25201%2520receptor%2520antagonists%2520based%2520on%2520conformationally%2520constrained%2520aromatic%2520amino%2520acids%2520and%2520discovery%2520of%2520a%2520potent%2520chimeric%2520opioid%2520agonist-neurokinin%25201%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2467%26epage%3D2476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rémond, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portevin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNanteuil, G.</span><span> </span><span class="NLM_article-title">Pharmacological profile of a novel series of NK1 antagonists. In vitro and in vivo potency of benzimidazolone derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1997&pages=843-868&author=G.+R%C3%A9mondauthor=B.+Portevinauthor=J.+Bonnetauthor=E.+Canetauthor=D.+Regoliauthor=G.+DeNanteuil&title=Pharmacological+profile+of+a+novel+series+of+NK1+antagonists.+In+vitro+and+in+vivo+potency+of+benzimidazolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25A9mond%26aufirst%3DG.%26aulast%3DPortevin%26aufirst%3DB.%26aulast%3DBonnet%26aufirst%3DJ.%26aulast%3DCanet%26aufirst%3DE.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DDeNanteuil%26aufirst%3DG.%26atitle%3DPharmacological%2520profile%2520of%2520a%2520novel%2520series%2520of%2520NK1%2520antagonists.%2520In%2520vitro%2520and%2520in%2520vivo%2520potency%2520of%2520benzimidazolone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1997%26volume%3D32%26spage%3D843%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Agnes, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badghisi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2868</span><span class="NLM_x">–</span> <span class="NLM_lpage">2875</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050921q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2868-2875&author=R.+S.+Agnesauthor=Y.+S.+Leeauthor=P.+Davisauthor=S.+W.+Maauthor=H.+Badghisiauthor=F.+Porrecaauthor=J.+Laiauthor=V.+J.+Hruby&title=Structure%E2%80%93activity+relationships+of+bifunctional+peptides+based+on+overlapping+pharmacophores+at+opioid+and+cholecystokinin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm050921q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050921q%26sid%3Dliteratum%253Aachs%26aulast%3DAgnes%26aufirst%3DR.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DBadghisi%26aufirst%3DH.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520bifunctional%2520peptides%2520based%2520on%2520overlapping%2520pharmacophores%2520at%2520opioid%2520and%2520cholecystokinin%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2868%26epage%3D2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Foran, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maszczynska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misicka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinborn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kream, R. M.</span><span> </span><span class="NLM_article-title">A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">7621</span><span class="NLM_x">–</span> <span class="NLM_lpage">7626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=7621-7626&author=S.+E.+Foranauthor=D.+B.+Carrauthor=A.+W.+Lipkowskiauthor=I.+Maszczynskaauthor=J.+E.+Marchandauthor=A.+Misickaauthor=M.+Beinbornauthor=A.+S.+Kopinauthor=R.+M.+Kream&title=A+substance+P-opioid+chimeric+peptide+as+a+unique+nontolerance-forming+analgesic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForan%26aufirst%3DS.%2BE.%26aulast%3DCarr%26aufirst%3DD.%2BB.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DMaszczynska%26aufirst%3DI.%26aulast%3DMarchand%26aufirst%3DJ.%2BE.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DBeinborn%26aufirst%3DM.%26aulast%3DKopin%26aufirst%3DA.%2BS.%26aulast%3DKream%26aufirst%3DR.%2BM.%26atitle%3DA%2520substance%2520P-opioid%2520chimeric%2520peptide%2520as%2520a%2520unique%2520nontolerance-forming%2520analgesic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D7621%26epage%3D7626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Fragments, network biology and designing multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=156-160&author=R.+Morphyauthor=Z.+Rankovic&title=Fragments%2C+network+biology+and+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFragments%252C%2520network%2520biology%2520and%2520designing%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D156%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Wermuth, C. G.</span><span> </span><span class="NLM_article-title">Selective optimization of side activities: the SOSA approach</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=160-164&author=C.+G.+Wermuth&title=Selective+optimization+of+side+activities%3A+the+SOSA+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26atitle%3DSelective%2520optimization%2520of%2520side%2520activities%253A%2520the%2520SOSA%2520approach%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D160%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Martin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochwil, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, A.</span><span> </span><span class="NLM_article-title">Discovery of the first nonpeptidic, small-molecule, highly selective somatostatin receptor subtype 5 antagonists: a chemogenomics approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6291</span><span class="NLM_x">–</span> <span class="NLM_lpage">6294</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701143p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6291-6294&author=R.+E.+Martinauthor=L.+G.+Greenauthor=W.+Gubaauthor=N.+Kratochwilauthor=A.+Christ&title=Discovery+of+the+first+nonpeptidic%2C+small-molecule%2C+highly+selective+somatostatin+receptor+subtype+5+antagonists%3A+a+chemogenomics+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm701143p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701143p%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DKratochwil%26aufirst%3DN.%26aulast%3DChrist%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520the%2520first%2520nonpeptidic%252C%2520small-molecule%252C%2520highly%2520selective%2520somatostatin%2520receptor%2520subtype%25205%2520antagonists%253A%2520a%2520chemogenomics%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6291%26epage%3D6294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Gattrell, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambrook Smith, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. J.</span><span> </span><span class="NLM_article-title">An example of designed multiple ligands spanning protein classes: dual MCH-1R antagonists/DPPIV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2464</span><span class="NLM_x">–</span> <span class="NLM_lpage">2469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2464-2469&author=W.+T.+Gattrellauthor=C.+P.+Sambrook+Smithauthor=A.+J.+Smith&title=An+example+of+designed+multiple+ligands+spanning+protein+classes%3A+dual+MCH-1R+antagonists%2FDPPIV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGattrell%26aufirst%3DW.%2BT.%26aulast%3DSambrook%2BSmith%26aufirst%3DC.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BJ.%26atitle%3DAn%2520example%2520of%2520designed%2520multiple%2520ligands%2520spanning%2520protein%2520classes%253A%2520dual%2520MCH-1R%2520antagonists%252FDPPIV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2464%26epage%3D2469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span> <span class="citation_source-book">Pipeline Pilot</span>, version <span class="NLM_edition">7.5.2</span>; <span class="NLM_publisher-name">Accelrys Software Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pipeline+Pilot%2C+version+7.5.2%3B+Accelrys+Software+Inc.%3A+San+Diego%2C+CA%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPipeline%2520Pilot%26pub%3DAccelrys%2520Software%2520Inc%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span> <span class="citation_source-book">Spotfire Decision Site</span>, version <span class="NLM_edition">9.1</span>; <span class="NLM_publisher-name">TIBCO Software Inc.</span>: <span class="NLM_publisher-loc">Somerville, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Spotfire+Decision+Site%2C+version+9.1%3B+TIBCO+Software+Inc.%3A+Somerville%2C+MA%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSpotfire%2520Decision%2520Site%26pub%3DTIBCO%2520Software%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0lhpHfbagPa6kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Xia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliski, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, D.</span><span> </span><span class="NLM_article-title">Classification of kinase inhibitors using a Bayesian model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4463</span><span class="NLM_x">–</span> <span class="NLM_lpage">4470</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Sgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4463-4470&author=X.+Xiaauthor=E.+G.+Maliskiauthor=P.+Gallantauthor=D.+Rogers&title=Classification+of+kinase+inhibitors+using+a+Bayesian+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Classification of Kinase Inhibitors Using a Bayesian Model</span></div><div class="casAuthors">Xia, Xiaoyang; Maliski, Edward G.; Gallant, Paul; Rogers, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4463-4470</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of Bayesian statistics to model both general (multifamily) and specific (single-target) kinase inhibitors is investigated.  The approach demonstrates an alternative to current computational methods applied to heterogeneous structure/activity data sets.  This approach operates rapidly and is readily modifiable as required.  A generalized model generated using inhibitor data from multiple kinase classes shows meaningful enrichment for several specific kinase targets.  Such an approach can be used to prioritize compds. for screening or to optimally select compds. from third-party data collections.  The obsd. benefit of the approach is finding compds. that are not structurally related to known actives, or novel targets for which there is not enough information to build a specific kinase model.  The general kinase model described was built from a basis of mostly tyrosine kinase inhibitors, with some serine/threonine inhibitors; all the test cases used in prediction were also on tyrosine kinase targets.  Confirming the applicability of this technique to other kinase families will be detd. once those biol. assays become available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrySh6p6L1C8rVg90H21EOLACvtfcHk0lgQ1BvETLxG_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Sgu78%253D&md5=6a7a80edee72fc9d33709a7dfdb7f0b5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm0303195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303195%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DX.%26aulast%3DMaliski%26aufirst%3DE.%2BG.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DRogers%26aufirst%3DD.%26atitle%3DClassification%2520of%2520kinase%2520inhibitors%2520using%2520a%2520Bayesian%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4463%26epage%3D4470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span>HUGO Gene Nomenclature Committee at the European Bioinformatics Institute. <a href="http://www.genenames.org/" class="extLink">http://www.genenames.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=HUGO+Gene+Nomenclature+Committee+at+the+European+Bioinformatics+Institute.+http%3A%2F%2Fwww.genenames.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Wilming, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevanion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrow, J. L.</span><span> </span><span class="NLM_article-title">The vertebrate genome annotation (Vega) database</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">D753</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=D753-760&author=L.+G.+Wilmingauthor=J.+G.+Gilbertauthor=K.+Howeauthor=S.+Trevanionauthor=T.+Hubbardauthor=J.+L.+Harrow&title=The+vertebrate+genome+annotation+%28Vega%29+database"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilming%26aufirst%3DL.%2BG.%26aulast%3DGilbert%26aufirst%3DJ.%2BG.%26aulast%3DHowe%26aufirst%3DK.%26aulast%3DTrevanion%26aufirst%3DS.%26aulast%3DHubbard%26aufirst%3DT.%26aulast%3DHarrow%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520vertebrate%2520genome%2520annotation%2520%2528Vega%2529%2520database%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3DD753%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">The UniProt Consortium</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Reorganizing the protein space at the Universal Protein Resource (UniProt)</span>.  <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D71</span><span class="NLM_x">–</span> <span class="NLM_lpage">D75</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D71-D75&author=The+UniProt+Consortium&title=Reorganizing+the+protein+space+at+the+Universal+Protein+Resource+%28UniProt%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DReorganizing%2520the%2520protein%2520space%2520at%2520the%2520Universal%2520Protein%2520Resource%2520%2528UniProt%2529%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD71%26epage%3DD75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span>Thomson_pharma_partnering. <a href="http://thomsonreuters.com/products_services/science/science_products/a-z/thomson_pharma_partnering" class="extLink">http://thomsonreuters.com/products_services/science/science_products/a-z/thomson_pharma_partnering</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson_pharma_partnering.+http%3A%2F%2Fthomsonreuters.com%2Fproducts_services%2Fscience%2Fscience_products%2Fa-z%2Fthomson_pharma_partnering."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span>Thomson Reuters Integrity. <a href="http://thomsonreuters.com/products_services/science/science_products/a-z/integrity" class="extLink">http://thomsonreuters.com/products_services/science/science_products/a-z/integrity</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Reuters+Integrity.+http%3A%2F%2Fthomsonreuters.com%2Fproducts_services%2Fscience%2Fscience_products%2Fa-z%2Fintegrity."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span>ADIS R&D Insight. <a href="http://adisinsight.com/rd-insight/" class="extLink">http://adisinsight.com/rd-insight/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ADIS+R%26D+Insight.+http%3A%2F%2Fadisinsight.com%2Frd-insight%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span>Citeline. <a href="http://www.citeline.com/" class="extLink">http://www.citeline.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Citeline.+http%3A%2F%2Fwww.citeline.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span>Medline. <a href="http://www.nlm.nih.gov/bsd/pmresources.html" class="extLink">http://www.nlm.nih.gov/bsd/pmresources.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Medline.+http%3A%2F%2Fwww.nlm.nih.gov%2Fbsd%2Fpmresources.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span>Embase. <a href="http://www.embase.com/home" class="extLink">http://www.embase.com/home</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Embase.+http%3A%2F%2Fwww.embase.com%2Fhome."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span>Knowledge Discovery Platform. <a href="http://www.medintelsolutions.com" class="extLink">http://www.medintelsolutions.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Knowledge+Discovery+Platform.+http%3A%2F%2Fwww.medintelsolutions.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span>ClinicalTrials.gov. <a href="http://clinicaltrials.gov" class="extLink">http://clinicaltrials.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+http%3A%2F%2Fclinicaltrials.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span>TrialTrove. <a href="http://www.citeline.com/products/trialtrove/" class="extLink">http://www.citeline.com/products/trialtrove/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TrialTrove.+http%3A%2F%2Fwww.citeline.com%2Fproducts%2Ftrialtrove%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span>Solr. <a href="http://lucene.apache.org/solr" class="extLink">http://lucene.apache.org/solr</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Solr.+http%3A%2F%2Flucene.apache.org%2Fsolr."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Schuemie, M. J.; Jelier, R.; Kors, J. A.</span><span> </span><span class="NLM_article-title">Peregrine: Lightweight Gene Name Normalization by Dictionary Lookup</span>.  <span class="citation_source-book">Proceedings of the BioCreative II Workshop</span>; <span class="NLM_publisher-name">BioCreative Organizing Committees</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+J.+Schuemie&author=R.+Jelier&author=J.+A.+Kors&title=Proceedings+of+the+BioCreative+II+Workshop"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSchuemie%26aufirst%3DM.%2BJ.%26atitle%3DPeregrine%253A%2520Lightweight%2520Gene%2520Name%2520Normalization%2520by%2520Dictionary%2520Lookup%26btitle%3DProceedings%2520of%2520the%2520BioCreative%2520II%2520Workshop%26pub%3DBioCreative%2520Organizing%2520Committees%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Feldman, R.; Sanger, J.</span> <span class="citation_source-book">The Text Mining Handbook: Advanced Approaches in Analyzing Unstructured Data</span>; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=R.+Feldman&author=J.+Sanger&title=The+Text+Mining+Handbook%3A+Advanced+Approaches+in+Analyzing+Unstructured+Data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DR.%26btitle%3DThe%2520Text%2520Mining%2520Handbook%253A%2520Advanced%2520Approaches%2520in%2520Analyzing%2520Unstructured%2520Data%26pub%3DCambridge%2520University%2520Press%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span> </span><span class="NLM_article-title">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1093%2Fnar%2F22.22.4673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=7984417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADyaK2MXitlSgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=4673-4680&author=J.+D.+Thompsonauthor=D.+G.+Higginsauthor=T.+J.+Gibson&title=CLUSTAL+W%3A+improving+the+sensitivity+of+progressive+multiple+sequence+alignment+through+sequence+weighting%2C+position-specific+gap+penalties+and+weight+matrix+choice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</span></div><div class="casAuthors">Thompson, Julie D.; Higgins, Desmond G.; Gibson, Toby J.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4673-80</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The sensitivity of the commonly used progressive multiple sequence alignment method has been greatly improved for the alignment of divergent protein sequences.  Firstly, individual wts. are assigned to each sequence in a partial alignment in order to down-wt. near-duplicate sequences and up-wt. the most divergent ones.  Secondly, amino acid substitution matrixes are varied at different alignment stages according to the divergence of the sequences to be aligned.  Thirdly, residue-specific gap penalties and locally reduced gap penalties in hydrophilic regions encourage new gaps in potential loop regions rather than regular secondary structure.  Fourthly, positions in early alignments where gaps have been opened receive locally reduced gap penalties to encourage the opening of new gaps at these positions.  These modifications are incorporated into a new program, CLUSTAL W which is freely available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox0BWqmybJqbVg90H21EOLACvtfcHk0lj9_ZSToLS0Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitlSgu74%253D&md5=b219f8f0a8ea118b20a3e23461b99ccf</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F22.22.4673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F22.22.4673%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26atitle%3DCLUSTAL%2520W%253A%2520improving%2520the%2520sensitivity%2520of%2520progressive%2520multiple%2520sequence%2520alignment%2520through%2520sequence%2520weighting%252C%2520position-specific%2520gap%2520penalties%2520and%2520weight%2520matrix%2520choice%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D4673%26epage%3D4680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Regina  Martínez</span>, <span class="hlFld-ContribAuthor ">Bruno  Di Geronimo</span>, <span class="hlFld-ContribAuthor ">Miryam  Pastor</span>, <span class="hlFld-ContribAuthor ">José María  Zapico</span>, <span class="hlFld-ContribAuthor ">Claire  Coderch</span>, <span class="hlFld-ContribAuthor ">Rostyslav  Panchuk</span>, <span class="hlFld-ContribAuthor ">Nadia  Skorokhyd</span>, <span class="hlFld-ContribAuthor ">Maciej  Maslyk</span>, <span class="hlFld-ContribAuthor ">Ana  Ramos</span>, <span class="hlFld-ContribAuthor ">Beatriz  de Pascual-Teresa</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1497. <a href="https://doi.org/10.3390/molecules25071497" title="DOI URL">https://doi.org/10.3390/molecules25071497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071497%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMultitarget%252BAnticancer%252BAgents%252BBased%252Bon%252BHistone%252BDeacetylase%252Band%252BProtein%252BKinase%252BCK2%252BInhibitors%26aulast%3DMart%25C3%25ADnez%26aufirst%3DRegina%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Perihan A.  Elzahhar</span>, <span class="hlFld-ContribAuthor ">Rana  Alaaeddine</span>, <span class="hlFld-ContribAuthor ">Tamer M.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Rasha  Nassra</span>, <span class="hlFld-ContribAuthor ">Azza  Ismail</span>, <span class="hlFld-ContribAuthor ">Benjamin S.K.  Chua</span>, <span class="hlFld-ContribAuthor ">Rebecca L.  Frkic</span>, <span class="hlFld-ContribAuthor ">John B.  Bruning</span>, <span class="hlFld-ContribAuthor ">Nadja  Wallner</span>, <span class="hlFld-ContribAuthor ">Tilo  Knape</span>, <span class="hlFld-ContribAuthor ">Andreas  von Knethen</span>, <span class="hlFld-ContribAuthor ">Hala  Labib</span>, <span class="hlFld-ContribAuthor ">Ahmed F.  El-Yazbi</span>, <span class="hlFld-ContribAuthor ">Ahmed S.F.  Belal</span>. </span><span class="cited-content_cbyCitation_article-title">Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 562-582. <a href="https://doi.org/10.1016/j.ejmech.2019.02.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DShooting%252Bthree%252Binflammatory%252Btargets%252Bwith%252Ba%252Bsingle%252Bbullet%25253A%252BNovel%252Bmulti-targeting%252Banti-inflammatory%252Bglitazones%26aulast%3DElzahhar%26aufirst%3DPerihan%2BA.%26date%3D2019%26volume%3D167%26spage%3D562%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongming  Chen</span>, <span class="hlFld-ContribAuthor ">Udo  Bauer</span>, <span class="hlFld-ContribAuthor ">Ola  Engkvist</span>. </span><span class="cited-content_cbyCitation_article-title">Merged Multiple Ligands. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 247-274. <a href="https://doi.org/10.1002/9783527674381.ch9" title="DOI URL">https://doi.org/10.1002/9783527674381.ch9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch9%26sid%3Dliteratum%253Aachs%26atitle%3DMerged%252BMultiple%252BLigands%26aulast%3DChen%26aufirst%3DHongming%26date%3D2017%26date%3D2017%26spage%3D247%26epage%3D274%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita  Meleddu</span>, <span class="hlFld-ContribAuthor ">Simona  Distinto</span>, <span class="hlFld-ContribAuthor ">Angela  Corona</span>, <span class="hlFld-ContribAuthor ">Enzo  Tramontano</span>, <span class="hlFld-ContribAuthor ">Giulia  Bianco</span>, <span class="hlFld-ContribAuthor ">Claudia  Melis</span>, <span class="hlFld-ContribAuthor ">Filippo  Cottiglia</span>, <span class="hlFld-ContribAuthor ">Elias  Maccioni</span>. </span><span class="cited-content_cbyCitation_article-title">Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 130-136. <a href="https://doi.org/10.1080/14756366.2016.1238366" title="DOI URL">https://doi.org/10.1080/14756366.2016.1238366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2016.1238366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2016.1238366%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DIsatin%252Bthiazoline%252Bhybrids%252Bas%252Bdual%252Binhibitors%252Bof%252BHIV-1%252Breverse%252Btranscriptase%26aulast%3DMeleddu%26aufirst%3DRita%26date%3D2017%26date%3D2016%26volume%3D32%26issue%3D1%26spage%3D130%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Purwin</span>, <span class="hlFld-ContribAuthor ">J.  Hernández-Toribio</span>, <span class="hlFld-ContribAuthor ">C.  Coderch</span>, <span class="hlFld-ContribAuthor ">R.  Panchuk</span>, <span class="hlFld-ContribAuthor ">N.  Skorokhyd</span>, <span class="hlFld-ContribAuthor ">K.  Filipiak</span>, <span class="hlFld-ContribAuthor ">B.  de Pascual-Teresa</span>, <span class="hlFld-ContribAuthor ">A.  Ramos</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel dual-target agents for HDAC1 and CK2 inhibition. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (71)
                                     , 66595-66608. <a href="https://doi.org/10.1039/C6RA09717K" title="DOI URL">https://doi.org/10.1039/C6RA09717K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA09717K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA09717K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bdual-target%252Bagents%252Bfor%252BHDAC1%252Band%252BCK2%252Binhibition%26aulast%3DPurwin%26aufirst%3DM.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D71%26spage%3D66595%26epage%3D66608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vicente F.  Kuyoc-Carrillo</span>, <span class="hlFld-ContribAuthor ">José L.  Medina-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the Analysis of Multiple Activity Profile of Screening Data Using Computational Approaches. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2014,</strong> <em>75 </em>
                                    (5)
                                     , 313-323. <a href="https://doi.org/10.1002/ddr.21209" title="DOI URL">https://doi.org/10.1002/ddr.21209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21209%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DProgress%252Bin%252Bthe%252BAnalysis%252Bof%252BMultiple%252BActivity%252BProfile%252Bof%252BScreening%252BData%252BUsing%252BComputational%252BApproaches%26aulast%3DKuyoc-Carrillo%26aufirst%3DVicente%2BF.%26date%3D2014%26date%3D2014%26volume%3D75%26issue%3D5%26spage%3D313%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aurelie  Bornot</span>, <span class="hlFld-ContribAuthor ">Carolyn  Blackett</span>, <span class="hlFld-ContribAuthor ">Ola  Engkvist</span>, <span class="hlFld-ContribAuthor ">Clare  Murray</span>, <span class="hlFld-ContribAuthor ">Claus  Bendtsen</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Historical Bioactivity Data in the Deconvolution of Phenotypic Screens. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Screening</span><span> <strong>2014,</strong> <em>19 </em>
                                    (5)
                                     , 696-706. <a href="https://doi.org/10.1177/1087057113518966" title="DOI URL">https://doi.org/10.1177/1087057113518966</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057113518966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057113518966%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Screening%26atitle%3DThe%252BRole%252Bof%252BHistorical%252BBioactivity%252BData%252Bin%252Bthe%252BDeconvolution%252Bof%252BPhenotypic%252BScreens%26aulast%3DBornot%26aufirst%3DAurelie%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D5%26spage%3D696%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alleyn T.  Plowright</span>, <span class="hlFld-ContribAuthor ">Ola  Engkvist</span>, <span class="hlFld-ContribAuthor ">Adrian  Gill</span>, <span class="hlFld-ContribAuthor ">Laurent  Knerr</span>, <span class="hlFld-ContribAuthor ">Qing-Dong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Herzregeneration: Chancen und Aufgaben für die Wirkstoff-Forschung mit neuartigen chemischen und therapeutischen Methoden oder Agentien. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2014,</strong> <em>126 </em>
                                    (16)
                                     , 4138-4159. <a href="https://doi.org/10.1002/ange.201307034" title="DOI URL">https://doi.org/10.1002/ange.201307034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201307034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201307034%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DHerzregeneration%25253A%252BChancen%252Bund%252BAufgaben%252Bf%2525C3%2525BCr%252Bdie%252BWirkstoff-Forschung%252Bmit%252Bneuartigen%252Bchemischen%252Bund%252Btherapeutischen%252BMethoden%252Boder%252BAgentien%26aulast%3DPlowright%26aufirst%3DAlleyn%2BT.%26date%3D2014%26date%3D2014%26volume%3D126%26issue%3D16%26spage%3D4138%26epage%3D4159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alleyn T.  Plowright</span>, <span class="hlFld-ContribAuthor ">Ola  Engkvist</span>, <span class="hlFld-ContribAuthor ">Adrian  Gill</span>, <span class="hlFld-ContribAuthor ">Laurent  Knerr</span>, <span class="hlFld-ContribAuthor ">Qing-Dong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Heart Regeneration: Opportunities and Challenges for Drug Discovery with Novel Chemical and Therapeutic Methods or Agents. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2014,</strong> <em>53 </em>
                                    (16)
                                     , 4056-4075. <a href="https://doi.org/10.1002/anie.201307034" title="DOI URL">https://doi.org/10.1002/anie.201307034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201307034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201307034%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DHeart%252BRegeneration%25253A%252BOpportunities%252Band%252BChallenges%252Bfor%252BDrug%252BDiscovery%252Bwith%252BNovel%252BChemical%252Band%252BTherapeutic%252BMethods%252Bor%252BAgents%26aulast%3DPlowright%26aufirst%3DAlleyn%2BT.%26date%3D2014%26date%3D2014%26volume%3D53%26issue%3D16%26spage%3D4056%26epage%3D4075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chanchal  Hazra</span>, <span class="hlFld-ContribAuthor ">Tuhin  Samanta</span>, <span class="hlFld-ContribAuthor ">Venkataramanan  Mahalingam</span>. </span><span class="cited-content_cbyCitation_article-title">A resonance energy transfer approach for the selective detection of aromatic amino acids. </span><span class="cited-content_cbyCitation_journal-name">J. Mater. Chem. C</span><span> <strong>2014,</strong> <em>2 </em>
                                    (47)
                                     , 10157-10163. <a href="https://doi.org/10.1039/C4TC01954G" title="DOI URL">https://doi.org/10.1039/C4TC01954G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4TC01954G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4TC01954G%26sid%3Dliteratum%253Aachs%26jtitle%3DJ.%2520Mater.%2520Chem.%2520C%26atitle%3DA%252Bresonance%252Benergy%252Btransfer%252Bapproach%252Bfor%252Bthe%252Bselective%252Bdetection%252Bof%252Baromatic%252Bamino%252Bacids%26aulast%3DHazra%26aufirst%3DChanchal%26date%3D2014%26date%3D2014%26volume%3D2%26issue%3D47%26spage%3D10157%26epage%3D10163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Morphy</span>, <span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 449-472. <a href="https://doi.org/10.1016/B978-0-12-417205-0.00019-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-417205-0.00019-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417205-0.00019-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417205-0.00019-5%26sid%3Dliteratum%253Aachs%26atitle%3DMultitarget%252BDrugs%26aulast%3DMorphy%26aufirst%3DRichard%26date%3D2008%26spage%3D449%26epage%3D472%26pub%3DElsevier%26atitle%3DThe%252BPractice%252Bof%252BMedicinal%252BChemistry%26date%3D2008%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0014.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overview of the MCWs and the BWs. For a list of targets associated with a specific disease area, the MCWs are first applied (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). This set of analyses aims to estimate the feasibility of designing a dual-acting modulator for each possible pair of targets within the disease area from a medicinal chemistry perspective. The most interesting target pairs identified in the MCWs and the first BW are thereafter evaluated in the second BW (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). This workflow is target-centric and aims to improve understanding of the mechanistic overlap for each of the target pairs. Finally, the most promising target pairs from the MCWs and the BWs are further evaluated as potential candidates for starting a new drug discovery project.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Heat maps displaying the results from the MCWs (A–E) and the first BW (F). (A) Number of published studies reporting having activities for the same molecule on both targets. Note that CCR9 is not displayed in part A, since there are no recorded publications with dual-acting modulators of CCR9 and any other of the targets in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. (B) Number of known identical or similar compounds acting on both targets, including activity data for the targets from the same publication and when the activity data have been reported for identical (or similar) molecules in different publications. Data were flattened to a maximum of 100, and a white spot indicates that there are no known dual modulators for the targets; however, similar active compounds exist. (C) Number of compounds available for testing each potential hypothesis in an in vivo model. The compounds can be dual modulators and/or only active on one of the targets but can then be used in combination with another tool compound (also accessible from this interface) to test the hypothesis. Data were flattened to a maximum of 100. A star indicates the existence of dual modulators. A circle indicates that no dual modulator is available but tool compounds are available to test the hypothesis with a combination. (D) Overlap of the physicochemical properties between the molecules binding to the two targets (heavy atom count, ionization state, AlogP). The map shows the minimum value of those three overlaps. (E) Number of privileged substructures in common for the active molecules binding to the two different targets. (F) Number of text mining results for combination studies. For the parts A–E, the activity threshold is 1 μM, and “normal” filtering is applied; i.e., compounds from patents without reported biological activity given for the reported targets are included.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sequence similarity between the protein sequences of the targets. Protein sequence alignments were calculated with ClustalW using default parameters.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The heat map shows the percentage of identity between each protein sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Physicochemical property distributions for the active compounds of MLNR and GHSR. Activity threshold was 1 μM, and “normal” filtering is as described in the text. The heavy atom count distribution has been truncated at 75 to remove large peptides. This view is extracted for the Web interface associated with the MCW 4 and enabled drill down to more detailed data than the heat map alone for each pair of targets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Bioprocess map summarizing the literature knowledge for the biological roles of the NK1 receptor and MOR. A bioprocess map is built in the context of the second task of the BW (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Data 3">Supporting Information Data 3</a> for the PMID of the publications used). Such maps are used to asses if a biological rationale for modulating two targets in conjunction exists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Examples of dual-acting MLNR and GHSR modulators. The top part of the figure is a section of the heat map from the second MCW identifying dual-acting compounds or similar compounds active on one target each (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). The data were flattened to a maximum of 100. A white circle indicates that there is no dual-acting modulator known for the target pair; however, similar compounds exist that are active on one target each. The activity threshold was set to 100 nM and with the “normal” filtering option as described in the text. A privileged fragment is highlighted in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Examples of tool compounds found with MCW 3 for MLNR and GHSR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/medium/jm-2012-01653f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Dual-acting opioid/CCK and opioid/NK1 peptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm301653f/production/images/large/jm-2012-01653f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301653f&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Morgan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootendorst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lexchin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greyson, D.</span><span> </span><span class="NLM_article-title">The cost of drug development: a systematic review</span> <span class="citation_source-journal">Health Policy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fj.healthpol.2010.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=21256615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A280%3ADC%252BC3M3mtVentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4-17&author=S.+Morganauthor=P.+Grootendorstauthor=J.+Lexchinauthor=C.+Cunninghamauthor=D.+Greyson&title=The+cost+of+drug+development%3A+a+systematic+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The cost of drug development: a systematic review</span></div><div class="casAuthors">Morgan Steve; Grootendorst Paul; Lexchin Joel; Cunningham Colleen; Greyson Devon</div><div class="citationInfo"><span class="NLM_cas:title">Health policy (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  We aimed to systematically review and assess published estimates of the cost of developing new drugs.  METHODS:  We sought English language research articles containing original estimates of the cost of drug development that were published from 1980 to 2009, inclusive.  We searched seven databases and used citation tracing and expert referral to identify studies.  We abstracted qualifying studies for information about methods, data sources, study samples, and key results.  RESULTS:  Thirteen articles were found to meet our inclusion criteria.  Estimates of the cost of drug development ranged more than 9-fold, from USD$92 million cash (USD$161 million capitalized) to USD$883.6 million cash (USD$1.8 billion capitalized).  Differences in methods, data sources, and time periods explain some of the variation in estimates.  Lack of transparency limits many studies.  Confidential information provided by unnamed companies about unspecified products forms all or part of the data underlying 10 of the 13 studies.  CONCLUSIONS:  Despite three decades of research in this area, no published estimate of the cost of developing a drug can be considered a gold standard.  Studies on this topic should be subjected to reasonable audit and disclosure of - at the very least - the drugs which authors purport to provide development cost estimates for.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaRepHqeySwBfKb6ELK8t0fW6udTcc2eaYTk3o71-5orntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3mtVentQ%253D%253D&md5=9eed405260da92a72804838b2049dcb1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.healthpol.2010.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.healthpol.2010.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DS.%26aulast%3DGrootendorst%26aufirst%3DP.%26aulast%3DLexchin%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DC.%26aulast%3DGreyson%26aufirst%3DD.%26atitle%3DThe%2520cost%2520of%2520drug%2520development%253A%2520a%2520systematic%2520review%26jtitle%3DHealth%2520Policy%26date%3D2011%26volume%3D100%26spage%3D4%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Network pharmacology: the next paradigm in drug discovery</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1038%2Fnchembio.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=18936753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=682-690&author=A.+L.+Hopkins&title=Network+pharmacology%3A+the+next+paradigm+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology: the next paradigm in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">682-690</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The dominant paradigm in drug discovery is the concept of designing maximally selective ligands to act on individual drug targets.  However, many effective drugs act via modulation of multiple proteins rather than single targets.  Advances in systems biol. are revealing a phenotypic robustness and a network structure that strongly suggests that exquisitely selective compds., compared with multi-target drugs, may exhibit lower than desired clin. efficacy.  This new appreciation of the role of polypharmacol. has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity.  Integrating network biol. and polypharmacol. holds the promise of expanding the current opportunity space for druggable targets.  However, the rational design of polypharmacol. faces considerable challenges in the need for new methods to validate target combinations and optimize multiple structure-activity relationships while maintaining drug-like properties.  Advances in these areas are creating the foundation of the next paradigm in drug discovery: network pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqHy4FqkK-h7Vg90H21EOLACvtfcHk0lgzosBBPMEC1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK&md5=03b8be3ddbcab7dc65afd17df7ee8395</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.118%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DNetwork%2520pharmacology%253A%2520the%2520next%2520paradigm%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D682%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wishart, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassanali, M.</span><span> </span><span class="NLM_article-title">DrugBank: a knowledgebase for drugs, drug actions and drug targets</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">D901</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1093%2Fnar%2Fgkm958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=18048412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=D901-906&author=D.+S.+Wishartauthor=C.+Knoxauthor=A.+C.+Guoauthor=D.+Chengauthor=S.+Shrivastavaauthor=D.+Tzurauthor=B.+Gautamauthor=M.+Hassanali&title=DrugBank%3A+a+knowledgebase+for+drugs%2C+drug+actions+and+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank: a knowledgebase for drugs, drug actions and drug targets</span></div><div class="casAuthors">Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">Database Iss</span>),
    <span class="NLM_cas:pages">D901-D906</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank is a richly annotated resource that combines detailed drug data with comprehensive drug target and drug action information.  Since its first release in 2006, DrugBank has been widely used to facilitate in silico drug target discovery, drug design, drug docking or screening, drug metab. prediction, drug interaction prediction and general pharmaceutical education.  The latest version of DrugBank (release 2.0) has been expanded significantly over the previous release.  With ∼4900 drug entries, it now contains 60% more FDA-approved small mol. and biotech drugs including 10% more exptl.' drugs.  Significantly, more protein target data has also been added to the database, with the latest version of DrugBank contg. three times as many non-redundant protein or drug target sequences as before (1565 vs. 524).  Each DrugCard entry now contains more than 100 data fields with half of the information being devoted to drug/chem. data and the other half devoted to pharmacol., pharmacogenomic and mol. biol. data.  A no. of new data fields, including food-drug interactions, drug-drug interactions and exptl. ADME data have been added in response to numerous user requests.  DrugBank has also significantly improved the power and simplicity of its structure query and text query searches.  DrugBank is available at http://www.drugbank.ca.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqKjSWZe1ULVg90H21EOLACvtfcHk0lgzosBBPMEC1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSrs7Y%253D&md5=f8f8ca15f248b8c8b9c6d3bd0e85eec8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm958%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DShrivastava%26aufirst%3DS.%26aulast%3DTzur%26aufirst%3DD.%26aulast%3DGautam%26aufirst%3DB.%26aulast%3DHassanali%26aufirst%3DM.%26atitle%3DDrugBank%253A%2520a%2520knowledgebase%2520for%2520drugs%252C%2520drug%2520actions%2520and%2520drug%2520targets%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3DD901%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Yildırım, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusick, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabási, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, M.</span><span> </span><span class="NLM_article-title">Drug–target network</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1119-1126&author=M.+A.+Yild%C4%B1r%C4%B1mauthor=K.+I.+Gohauthor=M.+E.+Cusickauthor=A.+L.+Barab%C3%A1siauthor=M.+Vidal&title=Drug%E2%80%93target+network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYild%25C4%25B1r%25C4%25B1m%26aufirst%3DM.%2BA.%26aulast%3DGoh%26aufirst%3DK.%2BI.%26aulast%3DCusick%26aufirst%3DM.%2BE.%26aulast%3DBarab%25C3%25A1si%26aufirst%3DA.%2BL.%26aulast%3DVidal%26aufirst%3DM.%26atitle%3DDrug%25E2%2580%2593target%2520network%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1119%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mestres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregori-Puigjane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valverde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sole, R. V.</span><span> </span><span class="NLM_article-title">Data completeness—the Achilles heel of drug–target networks</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=983-984&author=J.+Mestresauthor=E.+Gregori-Puigjaneauthor=S.+Valverdeauthor=R.+V.+Sole&title=Data+completeness%E2%80%94the+Achilles+heel+of+drug%E2%80%93target+networks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMestres%26aufirst%3DJ.%26aulast%3DGregori-Puigjane%26aufirst%3DE.%26aulast%3DValverde%26aufirst%3DS.%26aulast%3DSole%26aufirst%3DR.%2BV.%26atitle%3DData%2520completeness%25E2%2580%2594the%2520Achilles%2520heel%2520of%2520drug%25E2%2580%2593target%2520networks%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D983%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Jalencas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestres, J.</span><span> </span><span class="NLM_article-title">On the origins of drug polypharmacology</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1039%2Fc2md20242e" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=80-87&author=X.+Jalencasauthor=J.+Mestres&title=On+the+origins+of+drug+polypharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2Fc2md20242e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20242e%26sid%3Dliteratum%253Aachs%26aulast%3DJalencas%26aufirst%3DX.%26aulast%3DMestres%26aufirst%3DJ.%26atitle%3DOn%2520the%2520origins%2520of%2520drug%2520polypharmacology%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D80%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Benson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pershadsingh, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittiboyina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pravenec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtz, T. W.</span><span> </span><span class="NLM_article-title">Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=993-1002&author=S.+C.+Bensonauthor=H.+A.+Pershadsinghauthor=C.+I.+Hoauthor=A.+Chittiboyinaauthor=P.+Desaiauthor=M.+Pravenecauthor=N.+Qiauthor=J.+Wangauthor=M.+A.+Averyauthor=T.+W.+Kurtz&title=Identification+of+telmisartan+as+a+unique+angiotensin+II+receptor+antagonist+with+selective+PPARgamma-modulating+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DS.%2BC.%26aulast%3DPershadsingh%26aufirst%3DH.%2BA.%26aulast%3DHo%26aufirst%3DC.%2BI.%26aulast%3DChittiboyina%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DP.%26aulast%3DPravenec%26aufirst%3DM.%26aulast%3DQi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAvery%26aufirst%3DM.%2BA.%26aulast%3DKurtz%26aufirst%3DT.%2BW.%26atitle%3DIdentification%2520of%2520telmisartan%2520as%2520a%2520unique%2520angiotensin%2520II%2520receptor%2520antagonist%2520with%2520selective%2520PPARgamma-modulating%2520activity%26jtitle%3DHypertension%26date%3D2004%26volume%3D43%26spage%3D993%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Benndorf, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwedhelm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, R. H.</span><span> </span><span class="NLM_article-title">Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension</span> <span class="citation_source-journal">Metabolism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1159</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fj.metabol.2006.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=16919533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlCisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=1159-1164&author=R.+A.+Benndorfauthor=T.+Rudolphauthor=D.+Appelauthor=E.+Schwedhelmauthor=R.+Maasauthor=F.+Schulzeauthor=E.+Silberhornauthor=R.+H.+Boger&title=Telmisartan+improves+insulin+sensitivity+in+nondiabetic+patients+with+essential+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension</span></div><div class="casAuthors">Benndorf, Ralf A.; Rudolph, Tanja; Appel, Daniel; Schwedhelm, Edzard; Maas, Renke; Schulze, Friedrich; Silberhorn, Elisabeth; Boeger, Rainer H.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1159-1164</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hypertension is a cardiovascular risk factor commonly assocd. with insulin resistance, the metabolic syndrome, and type 2 diabetes mellitus.  Recent in vitro data indicate that certain angiotensin receptor antagonists, for example, telmisartan, activate peroxisome proliferator-activated receptor γ (PPAR-γ) and increase adiponectin protein content in adipocytes.  By this means, they may improve insulin sensitivity in vivo.  To investigate the effect of antihypertensive treatment on insulin sensitivity and fasting adiponectin serum levels, 37 nondiabetic patients with essential hypertension were randomized to receive telmisartan, the calcium channel blocker nisoldipine, or their combination for 6 wk in a prospective, parallel group study.  Fasting serum glucose, insulin, and adiponectin were evaluated before, 3 wk (low dose), and 6 wk (high dose) after initiation of treatment.  Furthermore, the effect of telmisartan on PPAR-γ receptor activity was investigated in vitro using a PPAR-γ reporter gene assay.  As reported previously, telmisartan significantly enhanced PPAR-γ receptor activity in vitro.  At baseline, a pos. correlation between insulin serum levels and body mass index of investigated subjects was obsd., whereas body mass index and serum adiponectin levels were neg. assocd.  High-dose treatment with telmisartan but not with nisoldipine reduced serum insulin levels as well as the homeostasis model assessment of insulin resistance, but did not affect serum adiponectin levels.  In conclusion, in our study cohort of nondiabetic patients with essential hypertension, telmisartan improved insulin sensitivity by mechanisms apparently not involving adiponectin induction.  Future studies will demonstrate whether these telmisartan-induced effects may contribute to a blood pressure-independent redn. in cardiovascular morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLs94y4mjpcbVg90H21EOLACvtfcHk0liTMYOX4SD9fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlCisbk%253D&md5=dec4065c7925b138fa2721638b48cf41</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2006.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2006.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DBenndorf%26aufirst%3DR.%2BA.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DAppel%26aufirst%3DD.%26aulast%3DSchwedhelm%26aufirst%3DE.%26aulast%3DMaas%26aufirst%3DR.%26aulast%3DSchulze%26aufirst%3DF.%26aulast%3DSilberhorn%26aufirst%3DE.%26aulast%3DBoger%26aufirst%3DR.%2BH.%26atitle%3DTelmisartan%2520improves%2520insulin%2520sensitivity%2520in%2520nondiabetic%2520patients%2520with%2520essential%2520hypertension%26jtitle%3DMetabolism%26date%3D2006%26volume%3D55%26spage%3D1159%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Peters, J. U.</span>, Ed.  <span class="citation_source-book">Polypharmacology in Drug Discovery</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1002%2F9781118098141" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+U.+Peters&title=Polypharmacology+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F9781118098141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118098141%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26btitle%3DPolypharmacology%2520in%2520Drug%2520Discovery%26pub%3DWiley%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Morphy, J. R.; Harris, C. J.</span> <span class="citation_source-book">Designing Multi-Target Drugs</span>; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1039%2F9781849734912" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+R.+Morphy&author=C.+J.+Harris&title=Designing+Multi-Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2F9781849734912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849734912%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26btitle%3DDesigning%2520Multi-Target%2520Drugs%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">The use of multi-target drugs in the treatment of neurodegenerative diseases</span> <span class="citation_source-journal">Expert Rev. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1586%2Fecp.11.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFGgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=293-298&author=C.+J.+Van+der+Schyf&title=The+use+of+multi-target+drugs+in+the+treatment+of+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The use of multi-target drugs in the treatment of neurodegenerative diseases</span></div><div class="casAuthors">Van der Schyf, Cornelis J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-298</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders lead to increased mortality and morbidity in older patients, and are a great burden on society, where there is currently no approved treatment to prevent the progression of these diseases.  Many clinicians and basic scientists have become persuaded that a strategy aimed at the simultaneous targeting of multiple proteins (and therefore etiologies) involved in the development of a disease should be more beneficial than the currently accepted 'silver bullet' approach.  Select examples of multi-target drug candidates currently under investigation for neurodegenerative diseases are shown.  Importantly, such transition from a 'magic bullet' to a 'magic shotgun' approach may be key in designing future treatment regimens for neurodegenerative diseases and assocd. cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAwTj0XbQk3LVg90H21EOLACvtfcHk0lhnkGfn8m_h1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFGgsrk%253D&md5=7aa001180af3e144548f7f617aa12c2d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1586%2Fecp.11.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fecp.11.13%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520use%2520of%2520multi-target%2520drugs%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D4%26spage%3D293%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designing multiple ligands—medicinal chemistry strategies and challenges</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.2174%2F138161209787315594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=19199984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=587-600&author=R.+Morphyauthor=Z.+Rankovic&title=Designing+multiple+ligands%E2%80%94medicinal+chemistry+strategies+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Designing multiple ligands - medicinal chemistry strategies and challenges</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">587-600</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been widely recognized over the recent years that parallel modulation of multiple biol. targets can be beneficial for treatment of diseases with complex etiologies such as cancer asthma, and psychiatric disease.  In this article, current strategies for the generation of ligands with a specific multi-target profile (designed multiple ligands or DMLs) are described and a no. of illustrative example are given.  Designing multiple ligands is frequently a challenging endeavor for medicinal chemists, with the need to appropriately balance affinity for 2 or more targets while obtaining physicochem. and pharmacokinetic properties that are consistent with the administration of an oral drug.  Given that the properties of DMLs are influenced to a large extent by the proteomic superfamily to which the targets belong and the lead generation strategy that is pursued, an early assessment of the feasibility of any given DML project is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUo6NjoK5D-LVg90H21EOLACvtfcHk0lhnkGfn8m_h1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D&md5=fa34039be6e9c3b489f530fc74fd0346</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138161209787315594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315594%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigning%2520multiple%2520ligands%25E2%2580%2594medicinal%2520chemistry%2520strategies%2520and%2520challenges%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D587%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Designed multiple ligands: basic research vs clinical outcomes</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3353</span><span class="NLM_x">–</span> <span class="NLM_lpage">3387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.2174%2F092986712801215883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=22680630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOhtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3353-3387&author=L.+Costantinoauthor=D.+Barlocco&title=Designed+multiple+ligands%3A+basic+research+vs+clinical+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Designed multiple ligands: basic research vs clinical outcomes</span></div><div class="casAuthors">Costantino, L.; Barlocco, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3353-3387</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The clin. treatment of multifactorial pathologies (e.g. cancer, Alzheimer's disease, psychiatric disorders), is still a major challenge.  Many researches have been published dealing with the design of multiple ligands, able to act at the same time towards several targets relevant for a given pathol.  In the present review, the clin. results about these compds. have been reported, together with the design strategy adopted, in order to allow a crit. evaluation of the outcomes of these efforts.  What is emerging is that several effective design strategies of multitarget compds. are available, and the choice among these appears to be dependent on the therapeutic area considered.  However, at present, besides multitarget drugs discovered during optimization efforts by means of phenotypic assays, drug coadministrations or fixed dose formulations appear to be more useful therapeutic options than designed multiple ligands; this scenario will change when systems biol. will be able to select crit. targets, i.e. nodal proteins that should be inhibited in order to obtain a therapeutic action; at this point, the design of multiple ligands will allow a renaissance of medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobv_P2UM6L_7Vg90H21EOLACvtfcHk0ljQ5RCC6RA39Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOhtrrN&md5=82123bbafc10a19c65a0bc0c5be72546</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F092986712801215883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712801215883%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DDesigned%2520multiple%2520ligands%253A%2520basic%2520research%2520vs%2520clinical%2520outcomes%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3353%26epage%3D3387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzek, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karapetyan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dracheva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gindulyte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, S. H.</span><span> </span><span class="NLM_article-title">PubChem’s BioAssay Database</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D400</span><span class="NLM_x">–</span> <span class="NLM_lpage">D412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D400-D412&author=Y.+Wangauthor=J.+Xiaoauthor=T.+O.+Suzekauthor=J.+Zhangauthor=J.+Wangauthor=Z.+Zhouauthor=L.+Hanauthor=K.+Karapetyanauthor=S.+Drachevaauthor=B.+A.+Shoemakerauthor=E.+Boltonauthor=A.+Gindulyteauthor=S.+H.+Bryant&title=PubChem%E2%80%99s+BioAssay+Database"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DSuzek%26aufirst%3DT.%2BO.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DKarapetyan%26aufirst%3DK.%26aulast%3DDracheva%26aufirst%3DS.%26aulast%3DShoemaker%26aufirst%3DB.%2BA.%26aulast%3DBolton%26aufirst%3DE.%26aulast%3DGindulyte%26aufirst%3DA.%26aulast%3DBryant%26aufirst%3DS.%2BH.%26atitle%3DPubChem%25E2%2580%2599s%2520BioAssay%2520Database%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD400%26epage%3DD412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Gaulton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellis, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalovich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">ChEMBL: a large-scale bioactivity database for drug discovery</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1093%2Fnar%2Fgkr777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=21948594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D1100-D1107&author=A.+Gaultonauthor=L.+J.+Bellisauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Herseyauthor=Y.+Lightauthor=S.+McGlincheyauthor=D.+Michalovichauthor=B.+Al-Lazikaniauthor=J.+P.+Overington&title=ChEMBL%3A+a+large-scale+bioactivity+database+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL: a large-scale bioactivity database for drug discovery</span></div><div class="casAuthors">Gaulton, Anna; Bellis, Louisa J.; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Hersey, Anne; Light, Yvonne; McGlinchey, Shaun; Michalovich, David; Al-Lazikani, Bissan; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1100-D1107</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an Open Data database contg. binding, functional and ADMET information for a large no. of drug-like bioactive compds.  These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chem. biol. and drug-discovery research problems.  Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compds. and 5200 protein targets.  Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9e9jRENTtubVg90H21EOLACvtfcHk0ljQ5RCC6RA39Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN&md5=aedf7793e1ca54b6a4fa272ea3ef7d0e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr777%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DMichalovich%26aufirst%3DD.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DChEMBL%253A%2520a%2520large-scale%2520bioactivity%2520database%2520for%2520drug%2520discovery%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD1100%26epage%3DD1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Krejsa, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogalski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penzotti, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migeon, J. C.</span><span> </span><span class="NLM_article-title">Predicting ADME properties and side effects: the BioPrint approach</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=12951810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=470-480&author=C.+M.+Krejsaauthor=D.+Horvathauthor=S.+L.+Rogalskiauthor=J.+E.+Penzottiauthor=B.+Maoauthor=F.+Barbosaauthor=J.+C.+Migeon&title=Predicting+ADME+properties+and+side+effects%3A+the+BioPrint+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting ADME properties and side effects: The BioPrint approach</span></div><div class="casAuthors">Krejsa, Cecile M.; Horvath, Dragos; Rogalski, Sherri L.; Penzotti, Julie E.; Mao, Boryeu; Barbosa, Frederique; Migeon, Jacques C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">470-480</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Current Drugs</span>)
        </div><div class="casAbstract">A review.  Computational methods are increasingly used to streamline and enhance the lead discovery and optimization process.  However, accurate prediction of absorption, distribution, metab. and excretion (ADME) and adverse drug reactions (ADR) is often difficult, due to the complexity of underlying physiol. mechanisms.  Modeling approaches have been hampered by the lack of large, robust and standardized training datasets.  In an extensive effort to build such a dataset, the BioPrint database was constructed by systematic profiling of nearly all drugs available on the market, as well as numerous ref. compds.  The database is composed of several large datasets: compd. structures and mol. descriptors, in vitro ADME and pharmacol. profiles, and complementary clin. data including therapeutic use information, pharmacokinetics profiles and ADR profiles.  These data have allowed the development of computational tools designed to integrate a program of computational chem. into library design and lead development.  Models based on chem. structure are strengthened by in vitro results that can be used as addnl. compd. descriptors to predict complex in vivo endpoints.  The BioPrint pharmacoinformatics platform represents a systematic effort to accelerate the process of drug discovery, improve quant. structure-activity relationships and develop in vitro/in vivo assocns.  In this review, we will discuss the importance of training set size and diversity in model development, the implementation of linear and neighborhood modeling approaches, and the use of in silico methods to predict potential clin. liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQ71juUoErrVg90H21EOLACvtfcHk0ljCTjso4V898w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFymsLw%253D&md5=f8db4e37cc895d67bf4a82efe021c5c2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrejsa%26aufirst%3DC.%2BM.%26aulast%3DHorvath%26aufirst%3DD.%26aulast%3DRogalski%26aufirst%3DS.%2BL.%26aulast%3DPenzotti%26aufirst%3DJ.%2BE.%26aulast%3DMao%26aufirst%3DB.%26aulast%3DBarbosa%26aufirst%3DF.%26aulast%3DMigeon%26aufirst%3DJ.%2BC.%26atitle%3DPredicting%2520ADME%2520properties%2520and%2520side%2520effects%253A%2520the%2520BioPrint%2520approach%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2003%26volume%3D6%26spage%3D470%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span> <span class="citation_source-book">GOSTAR (GVK BIO Online Structure Activity Relationship Database)</span>; <span class="NLM_publisher-name">GVK Biosciences Private Limited, S-1, Phase-1, T.I.E.</span>: <span class="NLM_publisher-loc">Hyderabad, A.P, India</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GOSTAR+%28GVK+BIO+Online+Structure+Activity+Relationship+Database%29%3B+GVK+Biosciences+Private+Limited%2C+S-1%2C+Phase-1%2C+T.I.E.%3A+Hyderabad%2C+A.P%2C+India%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGOSTAR%2520%2528GVK%2520BIO%2520Online%2520Structure%2520Activity%2520Relationship%2520Database%2529%26pub%3DGVK%2520Biosciences%2520Private%2520Limited%252C%2520S-1%252C%2520Phase-1%252C%2520T.I.E%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Fliri, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loging, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R. A.</span><span> </span><span class="NLM_article-title">Drug effects viewed from a signal transduction network perspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8038</span><span class="NLM_x">–</span> <span class="NLM_lpage">8046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901001p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=8038-8046&author=A.+F.+Fliriauthor=W.+T.+Logingauthor=R.+A.+Volkmann&title=Drug+effects+viewed+from+a+signal+transduction+network+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901001p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901001p%26sid%3Dliteratum%253Aachs%26aulast%3DFliri%26aufirst%3DA.%2BF.%26aulast%3DLoging%26aufirst%3DW.%2BT.%26aulast%3DVolkmann%26aufirst%3DR.%2BA.%26atitle%3DDrug%2520effects%2520viewed%2520from%2520a%2520signal%2520transduction%2520network%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D8038%26epage%3D8046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Paolini, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapland, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoorn, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Global mapping of pharmacological space</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1038%2Fnbt1228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=16841068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=805-815&author=G.+V.+Paoliniauthor=R.+H.+Shaplandauthor=W.+P.+van+Hoornauthor=J.+S.+Masonauthor=A.+L.+Hopkins&title=Global+mapping+of+pharmacological+space"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Global mapping of pharmacological space</span></div><div class="casAuthors">Paolini, Gaia V.; Shapland, Richard H. B.; van Hoorn, Willem P.; Mason, Jonathan S.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We present the global mapping of pharmacol. space by the integration of several vast sources of medicinal chem. structure-activity relationships (SAR) data.  Our comprehensive mapping of pharmacol. space enables us to identify confidently the human targets for which chem. tools and drugs have been discovered to date.  The integration of SAR data from diverse sources by unique canonical chem. structure, protein sequence and disease indication enables the construction of a ligand-target matrix to explore the global relationships between chem. structure and biol. targets.  Using the data matrix, we are able to catalog the links between proteins in chem. space as a polypharmacol. interaction network.  We demonstrate that probabilistic models can be used to predict pharmacol. from a large knowledge base.  The relationships between proteins, chem. structures and drug-like properties provide a framework for developing a probabilistic approach to drug discovery that can be exploited to increase research productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV_CE47zZq8LVg90H21EOLACvtfcHk0lhIySCJVeAX-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFansb8%253D&md5=f559b34692cc903a1b503deb07030c5d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnbt1228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1228%26sid%3Dliteratum%253Aachs%26aulast%3DPaolini%26aufirst%3DG.%2BV.%26aulast%3DShapland%26aufirst%3DR.%2BH.%26aulast%3Dvan%2BHoorn%26aufirst%3DW.%2BP.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DGlobal%2520mapping%2520of%2520pharmacological%2520space%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D805%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Boran, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, R.</span><span> </span><span class="NLM_article-title">Systems approaches to polypharmacology and drug discovery</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=20443163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFCqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=297-309&author=A.+D.+Boranauthor=R.+Iyengar&title=Systems+approaches+to+polypharmacology+and+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Systems approaches to polypharmacology and drug discovery</span></div><div class="casAuthors">Boran, Aislyn D. W.; Iyengar, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-309</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Systems biol. uses exptl. and computational approaches to characterize large sample populations systematically, process large datasets, examine and analyze regulatory networks, and model reactions to det. how components are joined to form functional systems.  Systems biol. technologies, data and knowledge are particularly useful in understanding disease processes and drug actions.  An important area of integration between systems biol. and drug discovery is the concept of polypharmacol.: the treatment of diseases by modulating more than one target.  Polypharmacol. for complex diseases is likely to involve multiple drugs acting on distinct targets that are part of a network regulating physiol. responses.  This review discusses the current state of the systems-level understanding of diseases and both the therapeutic and adverse mechanisms of drug actions.  Drug-target networks can be used to identify multiple targets and to det. suitable combinations of drug targets or drugs.  Thus, the discovery of new drug therapies for complex diseases may be greatly aided by systems biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7lrjWtBIXI7Vg90H21EOLACvtfcHk0lhIySCJVeAX-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFCqtrk%253D&md5=b26a44ecd76a605816e08985ff8a576f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoran%26aufirst%3DA.%2BD.%26aulast%3DIyengar%26aufirst%3DR.%26atitle%3DSystems%2520approaches%2520to%2520polypharmacology%2520and%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D297%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Maglott, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruitt, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatusova, T.</span><span> </span><span class="NLM_article-title">Entrez Gene: gene-centered information at NCBI</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D52</span><span class="NLM_x">–</span> <span class="NLM_lpage">D57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D52-D57&author=D.+Maglottauthor=J.+Ostellauthor=K.+D.+Pruittauthor=T.+Tatusova&title=Entrez+Gene%3A+gene-centered+information+at+NCBI"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaglott%26aufirst%3DD.%26aulast%3DOstell%26aufirst%3DJ.%26aulast%3DPruitt%26aufirst%3DK.%2BD.%26aulast%3DTatusova%26aufirst%3DT.%26atitle%3DEntrez%2520Gene%253A%2520gene-centered%2520information%2520at%2520NCBI%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD52%26epage%3DD57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhIySCJVeAX-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lgxWcVRYPtzxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Patchett, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, R. P.</span><span> </span><span class="NLM_article-title">Privileged structures—an update</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=289-298&author=A.+A.+Patchettauthor=R.+P.+Nargund&title=Privileged+structures%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26atitle%3DPrivileged%2520structures%25E2%2580%2594an%2520update%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2000%26volume%3D35%26spage%3D289%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gloriam, D. E.</span><span> </span><span class="NLM_article-title">Chemogenomics of allosteric binding sites in GPCRs</span>.  <span class="citation_source-journal">Drug Discovery Today: Technol.</span> [Online eary access]. DOI: <span class="refDoi"> DOI: 10.1016/i.ddtec.2012.07.010</span> . Published Online:<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fi.ddtec.2012.07.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+E.+Gloriam&title=Chemogenomics+of+allosteric+binding+sites+in+GPCRs&doi=10.1016%2Fi.ddtec.2012.07.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fi.ddtec.2012.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fi.ddtec.2012.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DChemogenomics%2520of%2520allosteric%2520binding%2520sites%2520in%2520GPCRs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26doi%3D10.1016%2Fi.ddtec.2012.07.010%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Pang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. H.</span><span> </span><span class="NLM_article-title">A series of case studies: practical methodology for identifying antinociceptive multi-target drugs</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fj.drudis.2012.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=22269134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslymsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=425-434&author=M.+H.+Pangauthor=Y.+Kimauthor=K.+W.+Jungauthor=S.+Choauthor=D.+H.+Lee&title=A+series+of+case+studies%3A+practical+methodology+for+identifying+antinociceptive+multi-target+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A series of case studies: practical methodology for identifying antinociceptive multi-target drugs</span></div><div class="casAuthors">Pang, Min-Hee; Kim, Yuntae; Jung, Kyung Woon; Cho, Sunyoung; Lee, Doo H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">425-434</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the introduction of drug discovery based on single targets, the no. of newly developed drugs has steadily declined, and the reliability of the current drug-discovery paradigm has been unceasingly questioned.  As an alternative, an emerging approach pursuing multi-targeting drugs has arisen to reflect multifactorial diseases caused by the complex networks of various mechanisms.  The purpose of this paper is to review multi-target drugs and introduce our progress in establishing a practical methodol. for identifying antinociceptive multi-target drugs.  We have adopted a system of ex vivo efficacy screening using long-term potentiation in rat spinal cord as a surrogate biomarker for neuropathic pain.  A bait-target approach is also adopted to lure an unknown target combination that induces synergistic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooIysgrC1A57Vg90H21EOLACvtfcHk0ljMoJYasQ_c_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslymsb8%253D&md5=e049704990e8d69b5a91e2b11824fe7f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DJung%26aufirst%3DK.%2BW.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DD.%2BH.%26atitle%3DA%2520series%2520of%2520case%2520studies%253A%2520practical%2520methodology%2520for%2520identifying%2520antinociceptive%2520multi-target%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D425%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bureeva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvereva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryiskaya, T.</span><span> </span><span class="NLM_article-title">Manual annotation of protein interactions</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">563</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1007%2F978-1-60761-175-2_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=19597781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVKhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2009&pages=75-95&author=S.+Bureevaauthor=S.+Zverevaauthor=V.+Romanovauthor=T.+Serebryiskaya&title=Manual+annotation+of+protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Manual annotation of protein interactions</span></div><div class="casAuthors">Bureeva, Svetlana; Zvereva, Svetlana; Romanov, Valentin; Serebryiskaya, Tatiana</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">Protein Networks and Pathway Analysis</span>),
    <span class="NLM_cas:pages">75-95</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Protein interactions are the basic building blocks for assembly of pathways and networks.  Almost any biol. meaningful functionality (for instance, linear signaling pathways, chains of metabolic reactions, transcription factor dimmers, protein complexes of transcriptosome, gene-disease assocns.) can be represented as a combination of binary relationships between "network objects" (genes, proteins, RNA species, bioactive compds.).  Naturally, the assembled pathways and networks are only as good as their "weakest" link (i.e., a wrongly assigned interaction), and the errors multiply in multi-step pathways.  Therefore, the utility of "systems biol." is fundamentally dependent on quality and relevance of protein interactions.  The second important parameter is the sheer no. of interactions assembled in the database.  One needs a "crit. mass" of species-specific interactions in order to build cohesive networks for a gene list, not a constellation of non-connected proteins and protein pairs.  The third issue is semantic consistency between interactions of different types.  Transient phys. signal transduction interactions, reactions of endogenous metab., transcription factor-promoter binding, and kinetic drug-target interactions are all very different in nature.  Yet, they have to fit well into one database format and be consistent in order to be useful in reconstruction of cellular processes.  High-quality protein interactions are available in peer-reviewed "small expt." literature and, to a much smaller extent, patents.  However, it is very challenging to find the interactions, annotate with searchable (and computable) parameters, catalog in the database format in computer readable form, and assemble into a database.  There are hundreds of thousands of mammalian interactions scattered in tens of thousands of papers in a few thousands of scientific journals.  There are no widely used stds. for reporting the interactions in scientific texts and, therefore, text-mining tools have only limited applicability.  In order to generate a meaningful database of protein interactions, one needs a well-developed technol. of manual curation, equipped with computational solns., managerial procedures, quality control, and users' feedback.  Here we describe our ever-evolving annotation approach, the important annotation issues and our solns., and the mammalian protein interactions database MetaBase which we have been working on for over 8 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooFH7AtAKh17Vg90H21EOLACvtfcHk0ljMoJYasQ_c_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVKhu7w%253D&md5=c01400c84882d0e5ab98d6180868108d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2F978-1-60761-175-2_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60761-175-2_5%26sid%3Dliteratum%253Aachs%26aulast%3DBureeva%26aufirst%3DS.%26aulast%3DZvereva%26aufirst%3DS.%26aulast%3DRomanov%26aufirst%3DV.%26aulast%3DSerebryiskaya%26aufirst%3DT.%26atitle%3DManual%2520annotation%2520of%2520protein%2520interactions%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2009%26volume%3D563%26spage%3D75%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Inui, A.</span><span> </span><span class="NLM_article-title">Ghrelin: an orexigenic and somatotrophic signal from the stomach</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1038%2F35086018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=11483998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtVaqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=551-560&author=A.+Inui&title=Ghrelin%3A+an+orexigenic+and+somatotrophic+signal+from+the+stomach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin: An orexigenic and somatotrophic signal from the stomach</span></div><div class="casAuthors">Inui, Akio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">551-560</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 142 refs.  Ghrelin, an endogenous ligand for the growth hormone secretagogue receptor, is synthesized principally in the stomach and is released in response to fasting.  Ghrelin is structurally related to motilin and, together, they represent a novel family of gut-brain regulatory peptides.  In addn. to having a powerful effect on the secretion of growth hormone, ghrelin stimulates energy prodn. and signals directly to the hypothalamic regulatory nuclei that control energy homeostasis.  The study of ghrelin has extended the understanding of how growth is controlled, and has shown that the stomach is an important component of this system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBjETEEWi65bVg90H21EOLACvtfcHk0ljMoJYasQ_c_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtVaqtbo%253D&md5=ece77aa575192edd1ad0044cfd55b803</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2F35086018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35086018%26sid%3Dliteratum%253Aachs%26aulast%3DInui%26aufirst%3DA.%26atitle%3DGhrelin%253A%2520an%2520orexigenic%2520and%2520somatotrophic%2520signal%2520from%2520the%2520stomach%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D2%26spage%3D551%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochiki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwano, H.</span><span> </span><span class="NLM_article-title">The roles of motilin and ghrelin in gastrointestinal motility</span> <span class="citation_source-journal">Int. J. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">820794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=820794&author=T.+Ohnoauthor=E.+Mochikiauthor=H.+Kuwano&title=The+roles+of+motilin+and+ghrelin+in+gastrointestinal+motility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DT.%26aulast%3DMochiki%26aufirst%3DE.%26aulast%3DKuwano%26aufirst%3DH.%26atitle%3DThe%2520roles%2520of%2520motilin%2520and%2520ghrelin%2520in%2520gastrointestinal%2520motility%26jtitle%3DInt.%2520J.%2520Pept.%26date%3D2010%26volume%3D2010%26spage%3D820794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Bailey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basilla, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleury, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlek, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westaway, S. M.</span><span> </span><span class="NLM_article-title">The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6452</span><span class="NLM_x">–</span> <span class="NLM_lpage">6458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6452-6458&author=J.+M.+Baileyauthor=J.+S.+Scottauthor=J.+B.+Basillaauthor=V.+J.+Boltonauthor=I.+Boyfieldauthor=D.+G.+Evansauthor=E.+Fleuryauthor=T.+D.+Heightmanauthor=E.+M.+Jarvieauthor=K.+Lawlessauthor=K.+L.+Matthewsauthor=F.+McKayauthor=H.+Mokauthor=A.+Muirauthor=B.+S.+Orlekauthor=G.+J.+Sangerauthor=G.+Stempauthor=A.+J.+Stevensauthor=M.+Thompsonauthor=J.+Wardauthor=K.+Vaidyaauthor=S.+M.+Westaway&title=The+discovery+and+optimisation+of+benzazepine+sulfonamide+and+sulfones+as+potent+agonists+of+the+motilin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DBasilla%26aufirst%3DJ.%2BB.%26aulast%3DBolton%26aufirst%3DV.%2BJ.%26aulast%3DBoyfield%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DD.%2BG.%26aulast%3DFleury%26aufirst%3DE.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DJarvie%26aufirst%3DE.%2BM.%26aulast%3DLawless%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DK.%2BL.%26aulast%3DMcKay%26aufirst%3DF.%26aulast%3DMok%26aufirst%3DH.%26aulast%3DMuir%26aufirst%3DA.%26aulast%3DOrlek%26aufirst%3DB.%2BS.%26aulast%3DSanger%26aufirst%3DG.%2BJ.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DVaidya%26aufirst%3DK.%26aulast%3DWestaway%26aufirst%3DS.%2BM.%26atitle%3DThe%2520discovery%2520and%2520optimisation%2520of%2520benzazepine%2520sulfonamide%2520and%2520sulfones%2520as%2520potent%2520agonists%2520of%2520the%2520motilin%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6452%26epage%3D6458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Holzer, P.</span><span> </span><span class="NLM_article-title">Opioid receptors in the gastrointestinal tract</span> <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1016%2Fj.regpep.2009.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=19345246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1aju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2009&pages=11-17&author=P.+Holzer&title=Opioid+receptors+in+the+gastrointestinal+tract"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid receptors in the gastrointestinal tract</span></div><div class="casAuthors">Holzer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Opium is arguably one of the oldest herbal medicines, being used as analgesic, sedative and antidiarrheal drug for thousands of years.  These effects mirror the actions of the endogenous opioid system and are mediated by the principal μ-, κ- and δ-opioid receptors.  In the gut, met-enkephalin, leu-enkephalin, β-endorphin and dynorphin occur in both neurons and endocrine cells.  When released, opioid peptides activate opioid receptors on the enteric circuitry controlling motility and secretion.  As a result, inhibition of gastric emptying, increase in sphincter tone, induction of stationary motor patterns and blockade of peristalsis ensue.  Together with inhibition of ion and fluid secretion, these effects cause constipation, one of the most frequent and troublesome adverse reactions of opioid analgesic therapy.  Although laxatives are most frequently used to ameliorate opioid-induced bowel dysfunction, their efficacy is unsatisfactory.  Specific antagonism of peripheral opioid receptors is a more rational approach.  This goal is addressed by the use of opioid receptor antagonists with limited absorption such as oral prolonged-release naloxone and opioid receptor antagonists that do not penetrate the blood-brain barrier such as methylnaltrexone and alvimopan.  Preliminary evidence indicates that peripherally restricted opioid receptor antagonists may act as prokinetic drugs in their own right.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGott_ZsCD5bm7Vg90H21EOLACvtfcHk0ljO_KRmnRz3CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1aju7w%253D&md5=0add06dd2fd0767672c99daaf078d74b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.regpep.2009.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.regpep.2009.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DHolzer%26aufirst%3DP.%26atitle%3DOpioid%2520receptors%2520in%2520the%2520gastrointestinal%2520tract%26jtitle%3DRegul.%2520Pept.%26date%3D2009%26volume%3D155%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Shimizu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takewaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furness, J. B.</span><span> </span><span class="NLM_article-title">Tachykinins and their functions in the gastrointestinal tract</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1007%2Fs00018-007-7148-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=17952369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Cqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=295-311&author=Y.+Shimizuauthor=H.+Matsuyamaauthor=T.+Shiinaauthor=T.+Takewakiauthor=J.+B.+Furness&title=Tachykinins+and+their+functions+in+the+gastrointestinal+tract"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tachykinins and their functions in the gastrointestinal tract</span></div><div class="casAuthors">Shimizu, Y.; Matsuyama, H.; Shiina, T.; Takewaki, T.; Furness, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-311</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  In the gastrointestinal tract, tachykinins are peptide neurotransmitters in nerve circuits that regulate intestinal motility, secretion, and vascular functions.  Tachykinins also contribute to transmission from spinal afferents that innervate the gastrointestinal tract and have roles in the responses of the intestine to inflammation.  Tachykinins coexist with acetylcholine, the primary transmitter of excitatory neurons innervating the muscle, and act as a co-neurotransmitter of excitatory neurons.  Excitatory transmission is mediated through NK1 receptors (primarily on interstitial cells of Cajal) and NK2 receptors on the muscle.  Tachykinins participate in slow excitatory transmission at neuro-neuronal synapses, through NK1 and NK3 receptors, in both ascending and descending pathways affecting motility.  Activation of receptors (NK1 and NK2) on the epithelium causes fluid secretion.  Tachykinin receptors on immune cells are activated during inflammation of the gut.  Finally, tachykinins are released from the central terminals of gastrointestinal afferent neurons in the spinal cord, particularly in nociceptive pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreZGFy-NYRKbVg90H21EOLACvtfcHk0li--P4rvVdEcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Cqsbo%253D&md5=2965d955343372e4c49c93e53cab5a68</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7148-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7148-1%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DMatsuyama%26aufirst%3DH.%26aulast%3DShiina%26aufirst%3DT.%26aulast%3DTakewaki%26aufirst%3DT.%26aulast%3DFurness%26aufirst%3DJ.%2BB.%26atitle%3DTachykinins%2520and%2520their%2520functions%2520in%2520the%2520gastrointestinal%2520tract%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D295%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Walsh, S.; Heilig, M.; Nuzzo, A. P.; Henderson, P.; Lofwall, R. M.</span><span> </span><span class="NLM_article-title">Effects of the NK(1) antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers</span>.  <span class="citation_source-journal">Addict. Biol.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1111/j.1369-1600.2011.00419.x</span> . Published Online: Jan 19,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1111%2Fj.1369-1600.2011.00419.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+Walsh&author=M.+Heilig&author=A.+P.+Nuzzo&author=P.+Henderson&author=R.+M.+Lofwall&title=Effects+of+the+NK%281%29+antagonist%2C+aprepitant%2C+on+response+to+oral+and+intranasal+oxycodone+in+prescription+opioid+abusers&doi=10.1111%2Fj.1369-1600.2011.00419.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2011.00419.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2011.00419.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DS.%26atitle%3DEffects%2520of%2520the%2520NK%25281%2529%2520antagonist%252C%2520aprepitant%252C%2520on%2520response%2520to%2520oral%2520and%2520intranasal%2520oxycodone%2520in%2520prescription%2520opioid%2520abusers%26jtitle%3DAddict.%2520Biol.%26doi%3D10.1111%2Fj.1369-1600.2011.00419.x%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Vardanyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumirov, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichol, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liktor-Busa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6135</span><span class="NLM_x">–</span> <span class="NLM_lpage">6142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6135-6142&author=R.+Vardanyanauthor=V.+K.+Kumirovauthor=G.+S.+Nicholauthor=P.+Davisauthor=E.+Liktor-Busaauthor=D.+Rankinauthor=E.+Vargaauthor=T.+Vanderahauthor=F.+Porrecaauthor=J.+Laiauthor=V.+J.+Hruby&title=Synthesis+and+biological+evaluation+of+new+opioid+agonist+and+neurokinin-1+antagonist+bivalent+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVardanyan%26aufirst%3DR.%26aulast%3DKumirov%26aufirst%3DV.%2BK.%26aulast%3DNichol%26aufirst%3DG.%2BS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DLiktor-Busa%26aufirst%3DE.%26aulast%3DRankin%26aufirst%3DD.%26aulast%3DVarga%26aufirst%3DE.%26aulast%3DVanderah%26aufirst%3DT.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520opioid%2520agonist%2520and%2520neurokinin-1%2520antagonist%2520bivalent%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6135%26epage%3D6142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ballet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feytens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buysse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keresztes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Duppen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanden Broeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourwe, D.</span><span> </span><span class="NLM_article-title">Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2476</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1016285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2467-2476&author=S.+Balletauthor=D.+Feytensauthor=K.+Buysseauthor=N.+N.+Chungauthor=C.+Lemieuxauthor=S.+Tumatiauthor=A.+Keresztesauthor=J.+Van+Duppenauthor=J.+Laiauthor=E.+Vargaauthor=F.+Porrecaauthor=P.+W.+Schillerauthor=J.+Vanden+Broeckauthor=D.+Tourwe&title=Design+of+novel+neurokinin+1+receptor+antagonists+based+on+conformationally+constrained+aromatic+amino+acids+and+discovery+of+a+potent+chimeric+opioid+agonist-neurokinin+1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm1016285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1016285%26sid%3Dliteratum%253Aachs%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DFeytens%26aufirst%3DD.%26aulast%3DBuysse%26aufirst%3DK.%26aulast%3DChung%26aufirst%3DN.%2BN.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DTumati%26aufirst%3DS.%26aulast%3DKeresztes%26aufirst%3DA.%26aulast%3DVan%2BDuppen%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DVarga%26aufirst%3DE.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DVanden%2BBroeck%26aufirst%3DJ.%26aulast%3DTourwe%26aufirst%3DD.%26atitle%3DDesign%2520of%2520novel%2520neurokinin%25201%2520receptor%2520antagonists%2520based%2520on%2520conformationally%2520constrained%2520aromatic%2520amino%2520acids%2520and%2520discovery%2520of%2520a%2520potent%2520chimeric%2520opioid%2520agonist-neurokinin%25201%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2467%26epage%3D2476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rémond, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portevin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNanteuil, G.</span><span> </span><span class="NLM_article-title">Pharmacological profile of a novel series of NK1 antagonists. In vitro and in vivo potency of benzimidazolone derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1997&pages=843-868&author=G.+R%C3%A9mondauthor=B.+Portevinauthor=J.+Bonnetauthor=E.+Canetauthor=D.+Regoliauthor=G.+DeNanteuil&title=Pharmacological+profile+of+a+novel+series+of+NK1+antagonists.+In+vitro+and+in+vivo+potency+of+benzimidazolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25A9mond%26aufirst%3DG.%26aulast%3DPortevin%26aufirst%3DB.%26aulast%3DBonnet%26aufirst%3DJ.%26aulast%3DCanet%26aufirst%3DE.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DDeNanteuil%26aufirst%3DG.%26atitle%3DPharmacological%2520profile%2520of%2520a%2520novel%2520series%2520of%2520NK1%2520antagonists.%2520In%2520vitro%2520and%2520in%2520vivo%2520potency%2520of%2520benzimidazolone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1997%26volume%3D32%26spage%3D843%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Agnes, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badghisi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2868</span><span class="NLM_x">–</span> <span class="NLM_lpage">2875</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050921q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2868-2875&author=R.+S.+Agnesauthor=Y.+S.+Leeauthor=P.+Davisauthor=S.+W.+Maauthor=H.+Badghisiauthor=F.+Porrecaauthor=J.+Laiauthor=V.+J.+Hruby&title=Structure%E2%80%93activity+relationships+of+bifunctional+peptides+based+on+overlapping+pharmacophores+at+opioid+and+cholecystokinin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm050921q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050921q%26sid%3Dliteratum%253Aachs%26aulast%3DAgnes%26aufirst%3DR.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DBadghisi%26aufirst%3DH.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520bifunctional%2520peptides%2520based%2520on%2520overlapping%2520pharmacophores%2520at%2520opioid%2520and%2520cholecystokinin%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2868%26epage%3D2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Foran, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maszczynska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misicka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinborn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kream, R. M.</span><span> </span><span class="NLM_article-title">A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">7621</span><span class="NLM_x">–</span> <span class="NLM_lpage">7626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=7621-7626&author=S.+E.+Foranauthor=D.+B.+Carrauthor=A.+W.+Lipkowskiauthor=I.+Maszczynskaauthor=J.+E.+Marchandauthor=A.+Misickaauthor=M.+Beinbornauthor=A.+S.+Kopinauthor=R.+M.+Kream&title=A+substance+P-opioid+chimeric+peptide+as+a+unique+nontolerance-forming+analgesic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForan%26aufirst%3DS.%2BE.%26aulast%3DCarr%26aufirst%3DD.%2BB.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DMaszczynska%26aufirst%3DI.%26aulast%3DMarchand%26aufirst%3DJ.%2BE.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DBeinborn%26aufirst%3DM.%26aulast%3DKopin%26aufirst%3DA.%2BS.%26aulast%3DKream%26aufirst%3DR.%2BM.%26atitle%3DA%2520substance%2520P-opioid%2520chimeric%2520peptide%2520as%2520a%2520unique%2520nontolerance-forming%2520analgesic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D7621%26epage%3D7626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Fragments, network biology and designing multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=156-160&author=R.+Morphyauthor=Z.+Rankovic&title=Fragments%2C+network+biology+and+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFragments%252C%2520network%2520biology%2520and%2520designing%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D156%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Wermuth, C. G.</span><span> </span><span class="NLM_article-title">Selective optimization of side activities: the SOSA approach</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=160-164&author=C.+G.+Wermuth&title=Selective+optimization+of+side+activities%3A+the+SOSA+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26atitle%3DSelective%2520optimization%2520of%2520side%2520activities%253A%2520the%2520SOSA%2520approach%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D160%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Martin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochwil, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, A.</span><span> </span><span class="NLM_article-title">Discovery of the first nonpeptidic, small-molecule, highly selective somatostatin receptor subtype 5 antagonists: a chemogenomics approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6291</span><span class="NLM_x">–</span> <span class="NLM_lpage">6294</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701143p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6291-6294&author=R.+E.+Martinauthor=L.+G.+Greenauthor=W.+Gubaauthor=N.+Kratochwilauthor=A.+Christ&title=Discovery+of+the+first+nonpeptidic%2C+small-molecule%2C+highly+selective+somatostatin+receptor+subtype+5+antagonists%3A+a+chemogenomics+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm701143p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701143p%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DKratochwil%26aufirst%3DN.%26aulast%3DChrist%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520the%2520first%2520nonpeptidic%252C%2520small-molecule%252C%2520highly%2520selective%2520somatostatin%2520receptor%2520subtype%25205%2520antagonists%253A%2520a%2520chemogenomics%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6291%26epage%3D6294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Gattrell, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambrook Smith, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. J.</span><span> </span><span class="NLM_article-title">An example of designed multiple ligands spanning protein classes: dual MCH-1R antagonists/DPPIV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2464</span><span class="NLM_x">–</span> <span class="NLM_lpage">2469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2464-2469&author=W.+T.+Gattrellauthor=C.+P.+Sambrook+Smithauthor=A.+J.+Smith&title=An+example+of+designed+multiple+ligands+spanning+protein+classes%3A+dual+MCH-1R+antagonists%2FDPPIV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGattrell%26aufirst%3DW.%2BT.%26aulast%3DSambrook%2BSmith%26aufirst%3DC.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BJ.%26atitle%3DAn%2520example%2520of%2520designed%2520multiple%2520ligands%2520spanning%2520protein%2520classes%253A%2520dual%2520MCH-1R%2520antagonists%252FDPPIV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2464%26epage%3D2469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span> <span class="citation_source-book">Pipeline Pilot</span>, version <span class="NLM_edition">7.5.2</span>; <span class="NLM_publisher-name">Accelrys Software Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pipeline+Pilot%2C+version+7.5.2%3B+Accelrys+Software+Inc.%3A+San+Diego%2C+CA%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPipeline%2520Pilot%26pub%3DAccelrys%2520Software%2520Inc%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span> <span class="citation_source-book">Spotfire Decision Site</span>, version <span class="NLM_edition">9.1</span>; <span class="NLM_publisher-name">TIBCO Software Inc.</span>: <span class="NLM_publisher-loc">Somerville, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Spotfire+Decision+Site%2C+version+9.1%3B+TIBCO+Software+Inc.%3A+Somerville%2C+MA%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSpotfire%2520Decision%2520Site%26pub%3DTIBCO%2520Software%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0liEpDkDb7QB9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Xia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliski, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, D.</span><span> </span><span class="NLM_article-title">Classification of kinase inhibitors using a Bayesian model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4463</span><span class="NLM_x">–</span> <span class="NLM_lpage">4470</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Sgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4463-4470&author=X.+Xiaauthor=E.+G.+Maliskiauthor=P.+Gallantauthor=D.+Rogers&title=Classification+of+kinase+inhibitors+using+a+Bayesian+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Classification of Kinase Inhibitors Using a Bayesian Model</span></div><div class="casAuthors">Xia, Xiaoyang; Maliski, Edward G.; Gallant, Paul; Rogers, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4463-4470</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of Bayesian statistics to model both general (multifamily) and specific (single-target) kinase inhibitors is investigated.  The approach demonstrates an alternative to current computational methods applied to heterogeneous structure/activity data sets.  This approach operates rapidly and is readily modifiable as required.  A generalized model generated using inhibitor data from multiple kinase classes shows meaningful enrichment for several specific kinase targets.  Such an approach can be used to prioritize compds. for screening or to optimally select compds. from third-party data collections.  The obsd. benefit of the approach is finding compds. that are not structurally related to known actives, or novel targets for which there is not enough information to build a specific kinase model.  The general kinase model described was built from a basis of mostly tyrosine kinase inhibitors, with some serine/threonine inhibitors; all the test cases used in prediction were also on tyrosine kinase targets.  Confirming the applicability of this technique to other kinase families will be detd. once those biol. assays become available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrySh6p6L1C8rVg90H21EOLACvtfcHk0liJ9juPg6lRQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Sgu78%253D&md5=6a7a80edee72fc9d33709a7dfdb7f0b5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm0303195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303195%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DX.%26aulast%3DMaliski%26aufirst%3DE.%2BG.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DRogers%26aufirst%3DD.%26atitle%3DClassification%2520of%2520kinase%2520inhibitors%2520using%2520a%2520Bayesian%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4463%26epage%3D4470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span>HUGO Gene Nomenclature Committee at the European Bioinformatics Institute. <a href="http://www.genenames.org/" class="extLink">http://www.genenames.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=HUGO+Gene+Nomenclature+Committee+at+the+European+Bioinformatics+Institute.+http%3A%2F%2Fwww.genenames.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Wilming, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevanion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrow, J. L.</span><span> </span><span class="NLM_article-title">The vertebrate genome annotation (Vega) database</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">D753</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=D753-760&author=L.+G.+Wilmingauthor=J.+G.+Gilbertauthor=K.+Howeauthor=S.+Trevanionauthor=T.+Hubbardauthor=J.+L.+Harrow&title=The+vertebrate+genome+annotation+%28Vega%29+database"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilming%26aufirst%3DL.%2BG.%26aulast%3DGilbert%26aufirst%3DJ.%2BG.%26aulast%3DHowe%26aufirst%3DK.%26aulast%3DTrevanion%26aufirst%3DS.%26aulast%3DHubbard%26aufirst%3DT.%26aulast%3DHarrow%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520vertebrate%2520genome%2520annotation%2520%2528Vega%2529%2520database%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3DD753%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">The UniProt Consortium</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Reorganizing the protein space at the Universal Protein Resource (UniProt)</span>.  <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D71</span><span class="NLM_x">–</span> <span class="NLM_lpage">D75</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D71-D75&author=The+UniProt+Consortium&title=Reorganizing+the+protein+space+at+the+Universal+Protein+Resource+%28UniProt%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DReorganizing%2520the%2520protein%2520space%2520at%2520the%2520Universal%2520Protein%2520Resource%2520%2528UniProt%2529%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD71%26epage%3DD75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span>Thomson_pharma_partnering. <a href="http://thomsonreuters.com/products_services/science/science_products/a-z/thomson_pharma_partnering" class="extLink">http://thomsonreuters.com/products_services/science/science_products/a-z/thomson_pharma_partnering</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson_pharma_partnering.+http%3A%2F%2Fthomsonreuters.com%2Fproducts_services%2Fscience%2Fscience_products%2Fa-z%2Fthomson_pharma_partnering."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span>Thomson Reuters Integrity. <a href="http://thomsonreuters.com/products_services/science/science_products/a-z/integrity" class="extLink">http://thomsonreuters.com/products_services/science/science_products/a-z/integrity</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Reuters+Integrity.+http%3A%2F%2Fthomsonreuters.com%2Fproducts_services%2Fscience%2Fscience_products%2Fa-z%2Fintegrity."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span>ADIS R&D Insight. <a href="http://adisinsight.com/rd-insight/" class="extLink">http://adisinsight.com/rd-insight/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ADIS+R%26D+Insight.+http%3A%2F%2Fadisinsight.com%2Frd-insight%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span>Citeline. <a href="http://www.citeline.com/" class="extLink">http://www.citeline.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Citeline.+http%3A%2F%2Fwww.citeline.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span>Medline. <a href="http://www.nlm.nih.gov/bsd/pmresources.html" class="extLink">http://www.nlm.nih.gov/bsd/pmresources.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Medline.+http%3A%2F%2Fwww.nlm.nih.gov%2Fbsd%2Fpmresources.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span>Embase. <a href="http://www.embase.com/home" class="extLink">http://www.embase.com/home</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Embase.+http%3A%2F%2Fwww.embase.com%2Fhome."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span>Knowledge Discovery Platform. <a href="http://www.medintelsolutions.com" class="extLink">http://www.medintelsolutions.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Knowledge+Discovery+Platform.+http%3A%2F%2Fwww.medintelsolutions.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span>ClinicalTrials.gov. <a href="http://clinicaltrials.gov" class="extLink">http://clinicaltrials.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+http%3A%2F%2Fclinicaltrials.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span>TrialTrove. <a href="http://www.citeline.com/products/trialtrove/" class="extLink">http://www.citeline.com/products/trialtrove/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TrialTrove.+http%3A%2F%2Fwww.citeline.com%2Fproducts%2Ftrialtrove%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span>Solr. <a href="http://lucene.apache.org/solr" class="extLink">http://lucene.apache.org/solr</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Solr.+http%3A%2F%2Flucene.apache.org%2Fsolr."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Schuemie, M. J.; Jelier, R.; Kors, J. A.</span><span> </span><span class="NLM_article-title">Peregrine: Lightweight Gene Name Normalization by Dictionary Lookup</span>.  <span class="citation_source-book">Proceedings of the BioCreative II Workshop</span>; <span class="NLM_publisher-name">BioCreative Organizing Committees</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+J.+Schuemie&author=R.+Jelier&author=J.+A.+Kors&title=Proceedings+of+the+BioCreative+II+Workshop"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSchuemie%26aufirst%3DM.%2BJ.%26atitle%3DPeregrine%253A%2520Lightweight%2520Gene%2520Name%2520Normalization%2520by%2520Dictionary%2520Lookup%26btitle%3DProceedings%2520of%2520the%2520BioCreative%2520II%2520Workshop%26pub%3DBioCreative%2520Organizing%2520Committees%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Feldman, R.; Sanger, J.</span> <span class="citation_source-book">The Text Mining Handbook: Advanced Approaches in Analyzing Unstructured Data</span>; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=R.+Feldman&author=J.+Sanger&title=The+Text+Mining+Handbook%3A+Advanced+Approaches+in+Analyzing+Unstructured+Data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DR.%26btitle%3DThe%2520Text%2520Mining%2520Handbook%253A%2520Advanced%2520Approaches%2520in%2520Analyzing%2520Unstructured%2520Data%26pub%3DCambridge%2520University%2520Press%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span> </span><span class="NLM_article-title">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm301653f&amp;key=10.1093%2Fnar%2F22.22.4673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm301653f&amp;key=7984417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm301653f&amp;key=1%3ACAS%3A528%3ADyaK2MXitlSgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=4673-4680&author=J.+D.+Thompsonauthor=D.+G.+Higginsauthor=T.+J.+Gibson&title=CLUSTAL+W%3A+improving+the+sensitivity+of+progressive+multiple+sequence+alignment+through+sequence+weighting%2C+position-specific+gap+penalties+and+weight+matrix+choice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</span></div><div class="casAuthors">Thompson, Julie D.; Higgins, Desmond G.; Gibson, Toby J.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4673-80</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The sensitivity of the commonly used progressive multiple sequence alignment method has been greatly improved for the alignment of divergent protein sequences.  Firstly, individual wts. are assigned to each sequence in a partial alignment in order to down-wt. near-duplicate sequences and up-wt. the most divergent ones.  Secondly, amino acid substitution matrixes are varied at different alignment stages according to the divergence of the sequences to be aligned.  Thirdly, residue-specific gap penalties and locally reduced gap penalties in hydrophilic regions encourage new gaps in potential loop regions rather than regular secondary structure.  Fourthly, positions in early alignments where gaps have been opened receive locally reduced gap penalties to encourage the opening of new gaps at these positions.  These modifications are incorporated into a new program, CLUSTAL W which is freely available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox0BWqmybJqbVg90H21EOLACvtfcHk0ljjcYQwbD2-DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitlSgu74%253D&md5=b219f8f0a8ea118b20a3e23461b99ccf</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F22.22.4673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F22.22.4673%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26atitle%3DCLUSTAL%2520W%253A%2520improving%2520the%2520sensitivity%2520of%2520progressive%2520multiple%2520sequence%2520alignment%2520through%2520sequence%2520weighting%252C%2520position-specific%2520gap%2520penalties%2520and%2520weight%2520matrix%2520choice%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D4673%26epage%3D4680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i19"><a href="/doi/suppl/10.1021/jm301653f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_55177"></div></div></div></div></div><hr /></hr><p class="last">Lists of terms used for the text mining in the BW 1 and list of PMIDs of the publications used to build the knowledge map in BW 2. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301653f/suppl_file/jm301653f_si_001.pdf">jm301653f_si_001.pdf (70.81 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301653f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm301653f%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301653f" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997fb28e3d3c9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
